REVIEW article

Front. Physiol., 15 June 2015

Sec. Membrane Physiology and Membrane Biophysics

Volume 6 - 2015 | https://doi.org/10.3389/fphys.2015.00168

Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potential

    JW

    Jakob Wolfart *

    DL

    Debora Laker

  • Oscar Langendorff Institute of Physiology, University of Rostock Rostock, Germany

Article metrics

View details

44

Citations

7k

Views

2,6k

Downloads

Abstract

Neurons continuously adapt the expression and functionality of their ion channels. For example, exposed to chronic excitotoxicity, neurons homeostatically downscale their intrinsic excitability. In contrast, the “acquired channelopathy” hypothesis suggests that proepileptic channel characteristics develop during epilepsy. We review cell type-specific channel alterations under different epileptic conditions and discuss the potential of channels that undergo homeostatic adaptations, as targets for antiepileptic drugs (AEDs). Most of the relevant studies have been performed on temporal lobe epilepsy (TLE), a widespread AED-refractory, focal epilepsy. The TLE patients, who undergo epilepsy surgery, frequently display hippocampal sclerosis (HS), which is associated with degeneration of cornu ammonis subfield 1 pyramidal cells (CA1 PCs). Although the resected human tissue offers insights, controlled data largely stem from animal models simulating different aspects of TLE and other epilepsies. Most of the cell type-specific information is available for CA1 PCs and dentate gyrus granule cells (DG GCs). Between these two cell types, a dichotomy can be observed: while DG GCs acquire properties decreasing the intrinsic excitability (in TLE models and patients with HS), CA1 PCs develop channel characteristics increasing intrinsic excitability (in TLE models without HS only). However, thorough examination of data on these and other cell types reveals the coexistence of protective and permissive intrinsic plasticity within neurons. These mechanisms appear differentially regulated, depending on the cell type and seizure condition. Interestingly, the same channel molecules that are upregulated in DG GCs during HS-related TLE, appear as promising targets for future AEDs and gene therapies. Hence, GCs provide an example of homeostatic ion channel adaptation which can serve as a primer when designing novel anti-epileptic strategies.

Introduction

The relationship between epileptic seizures and ion channels is typically focused on the proepileptic (meaning seizure-supporting) nature of ion channel abnormalities. This perspective, embodied in the terms “channelopathy” and “channelepsy” (Hoffman, 1995; Ptacek, 1997; De Lanerolle et al., 2004; Kullmann and Waxman, 2010; D'adamo et al., 2013), is fueled by the increasing number of ion channel mutations discovered in epilepsy patients (Biervert et al., 1998; Charlier et al., 1998; Singh et al., 1998, 2008; Zuberi et al., 1999; Heilstedt et al., 2001; Chioza et al., 2002; Schulte et al., 2006; Cavalleri et al., 2007; Tomlinson et al., 2010; Lachance-Touchette et al., 2011; Weckhuysen et al., 2013), and the seizure phenotypes of corresponding engineered channel mutants (Signorini et al., 1997; Schroeder et al., 1998; Smart et al., 1998; Spigelman et al., 2002; Ludwig et al., 2003; Peters et al., 2005; Huang et al., 2009; Ishii et al., 2009; Riazanski et al., 2011; Hedrich et al., 2014). In contrast to genetic channelopathies, an “acquired channelopathy” is declared when ion channel abnormalities develop independently of the genetic background (Waxman, 2001; Bernard et al., 2004; Poolos and Johnston, 2012). Thus, the prevailing view of progressive acquisition of proepileptic channel properties during epilepsy is conceptually similar to the old “seizures beget seizures” hypothesis (Gower, 1881; Hauser and Lee, 2002; Sills, 2007; Ben-Ari, 2008).

For those studying homeostasis, the acquired channelopathy scenario may appear puzzling; how is it possible that neurons exposed to an environment already hyperexcitable, further enhance their excitability in a potentially self-destructive manner? Usually, biological cells are well equipped to counteract detrimental excitation and especially neurons respond to extrinsic hyperexcitation with intrinsic hypoexcitability on all time scales (Davis and Bezprozvanny, 2001; Turrigiano and Nelson, 2004; Marder and Goaillard, 2006; Meier et al., 2015). Are these mechanisms of protective homeostasis disabled in epilepsy? And if so, is it the rule or rather the exception? It is important to answer these questions, because it will help to understand the mechanisms of seizures and antiepileptic drugs (AEDs). The prevailing AED strategy is to inhibit excitatory channels such as sodium (Na) and calcium (Ca) channels (Löscher et al., 2013). A more recent approach is to support a specific potassium (K) channel (further discussion below) (Tatulian et al., 2001; Faulkner and Burke, 2013). Generally, AED strategies imply relatively fixed ion channel repertoires, but channels are dynamically adjusted all the time and these changes are not well understood in particular with respect to epilepsy.

Most of the discussion on channel-related AED mechanisms of action takes place without mentioning cell types even though AED channel targets can have behaviorally opposed effects depending on which cell types are affected (Prakriya and Mennerick, 2000; He et al., 2002). Hence, to discuss antiepileptic strategies in a meaningful manner, the first step is to obtain an overview on available information about channel molecule alterations, cell types, and epilepsy model methods. The present review focuses on temporal lobe epilepsy (TLE), because the majority of the available data concern this most common form of partial epilepsies, which in turn account for 60% of all adult epilepsy cases (Tellez-Zenteno and Hernandez-Ronquillo, 2012). Some of the discussed channel mechanisms might also be relevant for other epilepsies as many TLE animal models display generalized seizures. Studies on the principal neurons of the hippocampal formation, especially cornu ammonis 1 (CA1) and dentate gyrus (DG), outnumber studies on other areas by far. This fact is mirrored in our list of acquired ion channel alterations (Table 1). Other cell types are expected to gain importance in the future and are also discussed in respective sections. We especially highlight channels with net inhibitory effects and relate these to existing or promising AED mechanisms of action (Table 2), asking whether certain cell types can signpost effective molecule target combinations for future AED and antiepileptic gene therapies.

Table 1

Type of cells and TLE/model Ion channel/current Regulation/methods References
DG GRANULE CELLS
HS/noHS human IKir2.x funct (vc, 0.1 mM Ba2+) Stegen et al., 2009
HS/no HS human Kir2.2 prot IP Stegen et al., 2012
HS/noHS human GABAAα1/α2
GABAAα3
GABAAβ2/β3
GABAAγ2
prot IP
± prot IP
prot IP
prot IP
Loup et al., 2000
HS/noHS human GABABR1a-b prot IP Munoz et al., 2002
HS/noHS human HCN1 RNAISH, prot IP Bender et al., 2003
HS/noHS human IH
HCN1
funct (vc, ZD7288)
prot IP
Stegen et al., 2012
TLE/autopsy human Kv7.5 ± prot IP Yus-Najera et al., 2003
TLE/autopsy human Nav1.1/1.2/1.3 ± RNAISH Whitaker et al., 2001
TLE/autopsy human Cav1.2
Cav1.3
Cav2.2/2.3
Cav2.1
prot IP
± prot IP
± prot IP
prot IP
Djamshidian et al., 2002
HS-iKA mouse IKir2.x
Kir2.1/2.2/2.3/2.4
funct (vc, 40μM Ba2+)
prot IP
Young et al., 2009
HS-iKA mouse K2P1.1
K2P6.1
prot IP
↑ prot IP
Young et al., 2009
HS-iKA mouse IKv1.x
Kv1.1
Kir2.1
funct (vc, DTX)
RNASC-PCR, prot IF
RNASC-PCR
Kirchheim et al., 2013
HS-iKA mouse GABAA α1/α5
GABAA α2
GABAA α3
GABAA γ2
prot IP
prot IP
± prot IP
prot IP
Bouilleret et al., 2000
HS-iKA mouse GABAAα2 prot IF Knuesel et al., 2001
HS-iKA mouse ItGABA-A funct Young et al., 2009
hKindl rat GABAAα4 syn ex prot EM Sun et al., 2007
hKindl rat INa ± funct Ketelaars et al., 2001
aKindl rat Nav1.1/1.2/1.6
Nav1.6
± prot IF
± RNAISH
Blumenfeld et al., 2009
aKindl mouse Nav1.6 ± prot IF Blumenfeld et al., 2009
sPilo rat Kv1.4
Kv4.2/KChiP2
± prot IP
± prot IP
Monaghan et al., 2008
sPilo rat IGABAeff
IGABApot
funct
± funct
Gibbs et al., 1997
sPilo rat IGABAeff
IGABApot
GABAAα1
GABAAα2/α3
GABAAα4
GABAAβ1
GABAAβ2
GABAAβ3 /δ /ε GABAγ1/γ2/γ3
funct
± funct
RNASC-PCR
±RNASC-PCR
RNASC-PCR
RNASC-PCR
± RNASC-PCR
RNASC-PCR
± RNASC-PCR
Brooks-Kayal et al., 1998
sPilo mouse GABAaα4
GABAaδ
GABAaγ2
1–4days 30days prot IP
prot IP
±1–4days60days prot IP
Peng et al., 2004
sPilo rat GABAAβ2
GABAAβ3
GABAAδ
GABAAγ2
surface prot W
surface prot W
± protsurface (), funct
surface prot W
Goodkin et al., 2008
sPilo rat HCN1 RNAISH Bender et al., 2003
sPilo rat TRP3
TRP6
1days–1week prot IP
1days–1week prot IP
Kim et al., 2013
sPilo rat, mouse ICav
Cav3.2
± funct
± prot IF
Becker et al., 2008
sPilo mouse ItGABA-A
IpGABA-A
GABAAα
GABAAδ
GABAAγ2
± funct
funct
syn/ex prot EM
syn/ex port EM
syn ex prot EM
Zhang et al., 2007
P20 sPilo rat GABAAα1 RNASC-PCR Raol et al., 2006b
P20 sKA rat GABAAα1 RNASC-PCR Raol et al., 2006b
sKA rat Kv4.2 3h,6h 24h RNAISH Francis et al., 1997
sKA rat Nav1.1
Nav1.2
Nav1.3
± 3–24h RNAISH
3–6h ± 24h RNAISH
3–6h24h RNAISH
Bartolomei et al., 1997
DG INTERNEURONS
sPilo rat KChiP1 (hilus) prot Monaghan et al., 2008
sPilo rat tGABAA(BCs)
GABAAδ(BCs)
6–8days funct
1week prot IF
Yu et al., 2013
sPilo mouse GABAAδ(BCs) prot IP Peng et al., 2004
DG GLIAL CELLS
HS/noHS human IKir funct Hinterkeuser et al., 2000
HS/noHS human Kir4.1 (hilus) prot Heuser et al., 2012
sPilo rat K2P3.1 prot Kim et al., 2008b
CA1 PYRAMIDAL CELLS
TLE/autopsy human Kv7.5 ± prot IP Yus-Najera et al., 2003
TLE/autopsy human Nav1.1/1.3
Nav1.2
± RNAISH
RNAISH
Whitaker et al., 2001
TLE/autopsy human Cav1.2/1.3
Cav2.1/2.2/2.3
± prot IP
± prot IP
Djamshidian et al., 2002
HS-iKA mouse GABAAα2 prot IF Knuesel et al., 2001
HS-iKA mouse GABAAα1/α3/α5
GABAAα2
GABAAγ2
prot IP
± prot IP
prot IP
Bouilleret et al., 2000
hKindl rat INa-window funct Ketelaars et al., 2001
aKindl rat Nav1.1/1.2/1.6
Nav1.6
± prot IF
± RNAISH
Blumenfeld et al., 2009
aKindl mouse Nav1.6 ± prot IF Blumenfeld et al., 2009
sPilo rat IA-type/dend funct (cc, 5 mM 4-AP) Bernard et al., 2004
sPilo rat Kv4.2/KChiP2 prot IP Monaghan et al., 2008
sPilo rat ISK funct (vc, UCL1684) Schulz et al., 2012
sPilo rat IGABAeff
IGABApot
funct
funct
Gibbs et al., 1997
sPilo rat ICl
CLC2
funct
prot IF, W
Ge et al., 2011
sPilo rat IH/dend
IH/soma
1h–5weeks funct
± 3days–5weeks funct
Jung et al., 2007, 2011
sPilo rat IH
HCN2
funct (vc, ZD7288)
prot (surface)
Marcelin et al., 2009
sPilo rat ICav funct (cc, 1 mM Ni2+) Sanabria et al., 2001
sPilo rat TRP3
TRP6
1days–1week prot IP
1days–1week prot IP
Kim et al., 2013
sPilo rat ICav3 funct (vc, 0.1 mM Ni2+) Su et al., 2002
sKA rat Kv4.2 ± 3h, 6h, 24h RNAISH Francis et al., 1997
sKA rat IKv1.x
Kv1.1
14days 30days funct (cc, 50 μM 4-AP)
14days30days prot IF/W
Sosanya et al., 2014
sKA rat HCN1
HCN2
RNAISH
RNAISH
Brewster et al., 2002
sKA rat IH 1–2days 28–30days funct Shin et al., 2008
sKA rat Nav1.1 Nav1.2 Nav1.3 ± 3–24h RNAISH
± 3–24h RNAISH
± 3h6h± 24h RNAISH
Bartolomei et al., 1997
CA1 GLIAL CELLS
TLE/autopsy human Kir4.1 prot IP Heuser et al., 2012
sPilo rat K2P3.1 ± prot Kim et al., 2008b
sKA rat Kv1.3 funct Menteyne et al., 2009
CA2 PYRAMIDAL CELLS
HS/noHS human GABAAα2
GABAAα1/α3
prot IP
prot IP
Loup et al., 2000
TLE/autopsy human Nav1.1/1.3
Nav1.2
± RNAISH
RNAISH
Whitaker et al., 2001
TLE/autopsy human Cav1.2/1.3
Cav2.1/2.2/2.3
± prot IP
± prot IP
Djamshidian et al., 2002
noHS-aKindl rat Nav1.1/1.2/1.6
Nav1.6
± prot IF
± RNAISH
Blumenfeld et al., 2009
CA3 PYRAMIDAL CELLS
HS/noHS human Nav1.1/1.3
Nav1.2
± RNAISH
RNAISH
Whitaker et al., 2001
TLE/autopsy human Cav1.3,
Cav2.2/2.3
Cav2.1
Cav1.2
± prot IP
± prot IP
prot IP
prot IP
Djamshidian et al., 2002
HS-iKA mouse GABAAα1/α2
GABAA α5
GABAAγ2
± prot IP
prot IP
prot IP
Bouilleret et al., 2000
aKindl rat Nav1.1/1.2
Nav1.6
± prot IF
prot IF, RNAISH
Blumenfeld et al., 2009
aKindl mouse Ipersist inward
Nav1.6
funct prot IF, RNAISH Blumenfeld et al., 2009
sKA rat Kv4.2 ± 3h,6h24h RNAISH Francis et al., 1997
sKA rat IKv1.x
Kv1.1
14days 30days funct
14days30days prot IF/W
Sosanya et al., 2014
sKA rat HCN1
HCN2
RNAISH
RNAISH
Brewster et al., 2002
sKA rat Nav1.1
Nav1.2
Nav1.3
± 3–24h RNAISH
± 3–24h RNAISH
± 3h6h± 24h RNAISH
Bartolomei et al., 1997
sPilo rat TRP3
TRP6
1days–1week prot IP
1days–1week prot IP
Kim et al., 2013
CA INTERNEURONS
ventral of iKA IH(CA3 O-LM) funct Dugladze et al., 2007
sPilo rat KChiP1 (CA3 SP) prot IP Monaghan et al., 2008
SUBICULAR NEURONS
sPilo rat ICa (PCs) funct (cc, 1 mM Ni2+) Wellmer et al., 2002
AMYGDALA NEURONS
a/hKindl rat Kv7.2 prot IP Penschuck et al., 2005
CORTICAL NEURONS
hKindl rat EC INav (layer II stellate cells)
Nav1.2/6 (layer II stellate cells)
Nav1.1/3 (layer II stellate cells)
funct
prot IF
± prot IF
Hargus et al., 2013
hKindl rat PC Kv1.6 (interneurons) funct, prot IF Gavrilovici et al., 2012
sKA rat EC IH (layer III PCs) 24h 1week funct (dendritic) Shah et al., 2004
THALAMIC NEURONS
sPilo mouse IA (VM relay cells)
Kv4.2 (surf)
funct
prot IF
Smith et al., 2012
sPilo mouse IT-Type (relay cells)
Cav3.1 (thalamus)
Cav3.2 (thalamus)
Cav 3.3 (thalamus)
± 4h10days31days funct
± 4h/10days/31days RNAPCR
± 4h10days31days RNAPCR
± 4h10days
± 31days RNAPCR
Graef et al., 2009
TISSUE LEVEL ANALYSIS
HS/noHS human Kv4.2 (hipp) ↑ prot W Aronica et al., 2009
TLE/autopsy human Kv7.5 (temporal cortex) ± prot IP Yus-Najera et al., 2003
TLE/autopsy human CLC2 (temporal lobe) ↓ RNAPCR Bertelli et al., 2007
HS-iKA mouse Kir3.2 (DG ML) ↓ prot IP Young et al., 2009
sKA rat HCN1/2 (EC) 24h = 1week prot W Shah et al., 2004
sKA rat HCN1 (CA1)
HCN2 (CA1)
1–228–30days prot W
± 1–2days28–30days prot W
Shin et al., 2008
sKA rat HCN1 (CA1/DG)
HCN1 (CA3)
HCN1 (EC)
HCN2 (CA1)
HCN2 (CA3)
HCN2 (DG)
HCN2 (EC)
± 24h7days/6weeks RNAPCR
± 24h7days ± 6weeks RNAPCR
± 24h/7days/6weeks RNAPCR
24h/7days/6weeks RNAPCR
24h± 7days/6weeks RNAPCR
24h± 7days6weeks RNAPCR24h± 7days/6weeks RNAPCR
Powell et al., 2008
sPilo rat Kv4.2 (CA1) 30days RNAPCR Bernard et al., 2004
sPilo rat Kv1.4/3.3/3.4/4.2/4.3 (DG) ± RNAPCR Rüschenschmidt et al., 2006
sPilo rat KChiP2 (CA1)
KChiP2 (DG)
Kv4.2 (CA1)
Kv4.2 (DG)
1week4weeks prot IF
1week ± 4weeks prot IF
1week ± 4weeks prot IF
1week ± 4weeks prot IF
Monaghan et al., 2008
sPilo rat Kv4.2 (CA1/2)
Kv4.2 (CA3)
Kv4.2 (DG)
2days ± 50days prot IF
2days50days prot IF
± prot IF
Su et al., 2008
sPilo rat K2P5.1 (CA1)
K2P5.1 (CA3)
K2P5.1 (DG)
3days–5weeks prot IF (cell loss)
3days–5weeks prot IF
3days–5weeks prot IF
Kim et al., 2009
sPilo rat SK1/2 (hipp)
SK3 (hipp)
SK1 (hipp)
SK2/3 (hipp)
10days ± chronic prot W
↓ prot W
± RNAPCR
↓ RNAPCR
Oliveira et al., 2010
sPilo rat SK1/2/3 (CA1)
SK2 (CA1)
SK1/3 (CA1)
↓ RNAPCR
↓ prot W
± prot W
Schulz et al., 2012
sPilo rat BK (hilus/CA3) ↓ prot IF/W Pacheco Otalora et al., 2008
sPilo rat HCN1 (CA1)
HCN2 (CA1)
3,6days3–5weeks prot W
3,6days ± 3–5weeks prot W
Jung et al., 2007
sPilo rat HCN1 (CA1) ↓ RNAPCR Marcelin et al., 2009
sPilo rat HCN1 (CA1-3/DG)
HCN2 (CA1)
HCN2 (CA2/3)
HCN2 (DG)
HCN4 (CA1-3/DG)
12h ± 2weeks11weeks prot IP
12h ± 7days5weeks prot IP
± 12h–5weeks prot IP
12h–5weeks prot IP
± 12h–5weeks prot IP
Oh et al., 2012
sPilo rat Kir2.1 (amyg, hipp, ctx)
Kir4.1 (hipp)
Kir4.1 (amyg, striat, ctx)
Kir5.1 (amyg, hipp, ctx)
± prot W
± prot W IP
↑ prot W IP
± prot W
Nagao et al., 2013
sPilo rat /mouse Cav3.2 (CA1) 5days ± chronic RNAPCR, prot W Becker et al., 2008
sPilo mouse Cav3.1 (hippocampus)
Cav3.2 (hippocampus)
Cav3.3 (hippocampus)
± 10days/31days RNAPCR
± 10days31days RNAPCR
± 10days/31days RNAPCR
Graef et al., 2009
noHS-aKindl rat HCN1 (CA1/3/DG/EC)
HCN2 (CA1/DG/EC)
HCN2 (CA3)
± partial/full RNAPCR
± partial/full RNAPCR
± partialfull RNAPCR
Powell et al., 2008
vKA rat Cav1.2/1.3 (CA1-3/DG)
Cav2.1/2.2 (CA1-3/DG)
Cav α2 (CA3 astrocyt)
± prot IP
± prot IP
↑ prot IP
Westenbroek et al., 1998

Ion channel changes during temporal lobe epilepsy.

1st column: aKindl, hKindl, Epilepsy susceptibility model via repeated electrical stimulation (kindling) of amygdala or hippocampal areas; BCs, Basket cell interneurons; CLC, Chloride channel; dend, Dendritic recording; EC, Entorhinal cortex; HS/noHS human, Tissue from TLE patients with hippocampal sclerosis (HS) compared to samples from TLE patients with mild or no HS (noHS); HS-iKA, intrahippocampal unilateral kainic acid (KA) injection status epilepticus (SE) TLE animal model with severe HS; KChiP, K channel interacting protein (enhances Kv4 function); O-LM, Interneurons projecting from stratum oriens to stratum lacunosum moleculare; PC, Piriform cortex sKA, systemic (intraperitoneal) KA injection SE TLE model; sPilo, systemic pilocarpine injection SE TLE model using adult rats; SP, Interneurons scattered in stratum pyramidale; ventral of iKA, Same iKA model as above but data collected in ventral (noHS) areas; vKA, intraventricular KA injection SE TLE model shows sclerosis in CA3. 2nd column: For ion channel nomenclature see text; amyg, Amygdala; ctx, Cortex; hipp, Hippocampus; IX, Current x measured (t/pGABAA, tonic/phasic current via GABAARs; GABAeff/pot, efficacy or potency of GABA application; striat, Striatum TRP, Transient receptor potential cation channels; 3rd column: ↑/↓, Up-/downregulation (interpreted as antiepileptic/stabilizing () or as proepileptic/excitatory () effect; ±, No difference; subscripts, time period in which the changes took place (otherwise chronic) and/or method (full/partial refers to kindling procedure) and/or subcellular location like synaptic (syn), extra - and/or peri synaptic (ex), and surface (surf); funct, Functionally (electrophysiologically) verified via, voltage-clamp (vc) or current-clamp (cc), or with pharmacology (drug); prot, Protein detection via immunofluorescence (IF) or immunoperoxidase (IP) or western blot (W) labeling, or electron microscopy (EM); ISH, RNA detection via in situ hybridization; P10/20 sPilo, systemic pilocarpine injection SE TLE model using postnatal day 10 or 20 rats; PCR, mRNA detection via reverse transcriptase (RT)PCR on the tissue level; SC-PCR, Single cell (cell type specific) RT-PCR.

Table 2

Ion channel AED, Seizure model Cell type/Method References
POTASSIUM CHANNELS
K2P2.1 GenTher (hip, EC, pre SE)/sPilo Hip neur recs, CellCult, EEG, behavior Dey et al., 2014
Kir1.1 Pregabaline/A Thal neur recs, HetEx Lee and Liou, 2014
Kir2.3 Tenidap/A* HetEx recs Liu et al., 2002
Kir2.3 Tenidap/A*/sPilo EEG, behavior Xu et al., 2013a
Kir3.1 ML297/MES/PTZ HetEx recs, behavior Kaufmann et al., 2013
Kir3.4
Kir6.2 Pregabaline/A H19-7 CellCult hip neur recs Huang et al., 2006
Kir6.x Cromakalim/diazoxide anoxia seizure model Field recs Mattia et al., 1994
Kv1.1 PTZ Behavior Lu et al., 2008
Kv1.1 GenTher (neo, post SE)/NCTX iTX NCTX PC recs, EEG Wykes et al., 2012
Kv1.1 Rapamycin/sKA Behavior Sosanya et al., 2014
Kv7.2/7.3 ICA-27243/MES/PTZ/aKindl Behavior, HetEx recs, Hip neur recs Roeloffs et al., 2008; Wickenden et al., 2008
Kv7.x? Somatostatin/Gen sPent/sKA CA1 PCs, field recs, behavior Qiu et al., 2008
Kv7.2/7.3 Flupirtine/A*/sKA/FNeo EEG, behavior Raol et al., 2009
Kv7.2/7.3 Retigabine/A CA3 PCs recs Kim et al., 2012
Kv7.2/7.3 Retigabine/A/case EEG, behavior Walleigh et al., 2013
Kv7.2/7.3 Retigabine/A HetEx recs Schenzer et al., 2005; Zhou et al., 2013
Kv7.2–7.5 ICA-105665 i.p./P2 EEG, behavior Kasteleijn-Nolst Trenite et al., 2013
Kv Del Lamotrigine/A CA1 PC recs Grunze et al., 1998
Kv Del Levetiracetam/A Hip neur recs, CellCult Madeja et al., 2003
Kv A-type Lamotrigine/A Hip neur recs, CellCult Huang et al., 2004
hERG Lamotrigine/A Phenytoin/A HetEx recs Danielsson et al., 2003, 2005
KCa (SK) EBIO/MES, PTZ Behavior Anderson et al., 2006
KCa (BK) Zonisamide/A H19-7 Hip neur recs, CellCult Huang et al., 2007
KCa2 SKA-19 i.p./aKindl/in vitro PTX/4-AP CA1 PC recs Coleman et al., 2015
Nav
GABAA RECEPTORS AND OTHER CHLORIDE CHANNELS
GABAAα1 GenTher (DG, pre SE)/sPilo DG, EG, behavior Raol et al., 2006a
IGABAA Retigabine/A Cort neur recs, CellCult Otto et al., 2002
Cl NpHR Optogenetic act/NCTX iTX EEG Wykes et al., 2012
GABA GenTher/CTZ/sKA CA1 PC recs, behavior Sun et al., 2013
HCN CHANNELS
IH Lamotrigine/A CA1 PCs, dendritic recs Poolos et al., 2002
IH Lamotrigine/A Interneurons (CA1O-LM?) Peng et al., 2010
IH Gabapentin/A CA1 PCs Surges et al., 2003

Inhibitory ion channel changes with antiepileptic potential.

1st column: ↑ ↓, Manipulated up (↑) and down (↓) regulation of respective ion channel interpreted as pro- or anticonvulsive (red and green, respectively). 2nd column: /A, approved drug as AED or /A* for another indication; /case, case report of centroparietal focal seizures stopped by Retigabine; /P2, phase 2 clinical study; /GenTher, in vivo gene therapy via stereotaxic intracranial injection of viral vectors in hippocampus (hip), entorhinal cortex (EC) or neocortex (neo). Tested in animal models: /aKindl, amygdala kindling seizure model; /FNeo, rat model of neonatal seizures via convulsant gas flurothyl; MES, maximal electroshock model of epilepsy; NCTX iTX, motorcortex tetanus toxin injection model of neocortical epilepsy; PTZ, systemic pentylenetetrazol injection model of epilepsy; hKindl, hippocampal kindling to SE seizure model; iKA, intrahippocampal unilateral kainic acid injection SE TLE model; Neo sKA, systemic KA injection SE model of neonatal seizures; sPilo, systemic pilocarpine injection SE TLE model; 3rd column: CellCult, cell culture, e.g., of primary fetal cortical neurons; Cor neur, cortical neurons; field recs, extracellular field recordings; HetEx, heterologous expression and pharmacological testing of cloned channels; Hip neur, hippocampal neurons, Cl NpHR, chloride pump halorhodopsin from Natronomonas pharaonis, NpHR; recs, electrophysiological recordings; Thal neur, thalamic neurons.

Temporal lobe epilepsy

TLE seizures start in the temporal lobe and impair the consciousness, among other symptoms (Blumenfeld and Meador, 2014). TLE is often refractory to AEDs; therefore, anterior temporal lobe resection is a standard treatment (De Tisi et al., 2011). In its most common form, TLE affects the medial temporal/limbic network with involvement of the entorhinal cortex, the amygdala, and the hippocampus with the DG and the CA regions 1-3 (hippocampus sensu strictu) (Spencer, 2002). The neuropathological correlate of TLE is hippocampal sclerosis (HS) (Margerison and Corsellis, 1966; Curia et al., 2014) and quite often is HS interpreted to be the cause of TLE (Blümcke et al., 2012). However, as human TLE is heterogeneous, it appears difficult to find even simple correlations between the severity of HS and epileptic seizures, let alone the certainty that HS causes TLE or indeed vice versa (King et al., 1997; Jefferys, 1999; Blümcke et al., 2002; Mathern et al., 2002; Sutula et al., 2003; De Lanerolle and Lee, 2005; Briellmann et al., 2007; Mueller et al., 2007). A widespread criterion for HS diagnosis is loss of more than half of the CA1 PCs (Wyler et al., 1992). Other structural changes associated to HS, are sprouting of the mossy fiber axons of DG granule cells (GCs) (Sutula et al., 1989), changed GC morphology (Isokawa and Levesque, 1991), and GC dispersion (GCD) (Houser, 1990). Severe HS is correlated with severe GCD (Thom et al., 2002), although this relationship is not always strict (Blümcke et al., 2013). Occasionally, studies counting cells per area confuse GCD with degeneration of GCs. However, GCs are only lost in extreme HS (Wyler grade IV), i.e., when most of the CA1 PCs have already degenerated (Wyler et al., 1992). More than 90% of the hippocampi resected during epilepsy surgery exhibit HS (Blümcke et al., 2012) but it should be kept in mind that the decision on surgery itself depends on HS because the success rates of epilepsy surgery are higher with diagnosis of a lesion (Jobst and Cascino, 2015). Unbiased postmortem studies reveal HS in about half of TLE patients (Thom et al., 2010).

Epilepsy surgery offers direct experimental access to living human hippocampal tissue but lack of proper control tissue makes animal models indispensable. Different approaches were used to simulate a chronic epileptic state with anatomical changes resembling TLE. Since human TLE is heterogeneous and has unknown causes, animal models can only reproduce partial aspects of the disease (Coulter et al., 2002; Morimoto et al., 2004). One hypothesis for TLE is an initial precipitating injury (Mathern et al., 2002). Therefore, most animal models generate a chronic epileptic state via one status epilepticus (SE). Widespread is SE induction via i.p. (systemic) injection of kainate (sKA) (Nadler et al., 1978; Ben-Ari, 1985) or pilocarpine (sPilo) (Turski et al., 1983, 1989). The sKA and sPilo models produce generalized seizures and bilateral brain damage, the extent of which depends on the SE-termination protocol (Schwob et al., 1980; Turski et al., 1983). Often, no HS or only mild forms of it (noHS) occur in sKA and sPilo models (Okazaki et al., 1999; Scharfman et al., 2000; Dietrich et al., 2005; Curia et al., 2014). In contrast, development of HS and GCD, as well as focal spontaneous TLE seizures, can be induced by intracranial (intrahippocampal) kainate injection (iKA) (Suzuki et al., 1995; Fritschy, 2004). Another TLE model, which reproduces HS and chronic (bilateral) seizures, is perforant path stimulation-induced non-convulsive- (Kienzler et al., 2009) or convulsive SE (Bumanglag and Sloviter, 2008). In addition, there are different forms of electrical stimulation (“kindling”) of amygdala or hippocampus (aKindl, hKindl) which mostly evoke seizures only during the stimulation (i.e., no chronic epilepsy), (Goddard et al., 1969; Mcnamara, 1984; Morimoto et al., 2004).

Dentate gyrus

The DG is often viewed as a strategic “gate keeper” of the hippocampus and failure in its filter function was hypothesized to be a potential cause for TLE seizures (Heinemann et al., 1992; Lothman et al., 1992; Hsu, 2007; Krook-Magnuson et al., 2015). An alternative hypothesis is that the DG does not actively contribute to hippocampal seizures (Sloviter, 1994; Liu et al., 2000; Harvey and Sloviter, 2005). The following changes were considered responsible for a proepileptic role of the DG (De Lanerolle et al., 1992; Mody et al., 1992b): (i) mossy fiber sprouting (Tauck and Nadler, 1985; Sutula et al., 1989), (ii) loss of specific interneurons (Sloviter, 1987; Magloczky and Freund, 2005), and (iii) intrinsic hyperexcitability of the principal DG neurons, the GCs (Magloczky et al., 1997; Beck et al., 1998; Dietrich et al., 1999; Coulter, 2000; De Lanerolle et al., 2003; Selke et al., 2006; Mehranfard et al., 2014a). In contrast to the last point, many studies concluded that TLE does not change DG GCs intrinsically (Mody et al., 1992a; Beck et al., 1996; Isokawa, 1996; Molnar and Nadler, 1999; Okazaki et al., 1999; Scharfman et al., 2003; Dietrich et al., 2005; Beck and Yaari, 2008). Contrary to both prior hypotheses, we found a decrease of the intrinsic excitability of GCs which was due to a reduction in input resistance (Rin); it occurred in samples of TLE patients with HS vs. mild/no HS as well as in iKA vs. control mice (Stegen et al., 2009, 2012; Young et al., 2009; Kirchheim et al., 2013). A reasonable question is: why are there so many disparate results on the same cell type (Vida, 2009)? With rare exceptions (Isokawa and Mello, 1991; Mehranfard et al., 2014b), most studies reporting unchanged GCs were those employing TLE models without HS. In TLE patients and the iKA TLE model, the Rin of DG GCs correlates with the degree of HS (Stegen et al., 2009, 2012; Young et al., 2009). Although it cannot be ruled out that some of the studies missed Rin differences due to methodological procedures, such as applying minimum Rin as cell selection criterion, low seal resistance sharp electrodes, or by dissociating GC somata from their dendritic conductances (Mehranfard et al., 2014b), the conservative conclusion currently is: in TLE with HS, the ion channel expression of GCs is more drastically changed than in TLE without HS. It is important to note that GC channel adaptations only occur in the HS area, i.e., where GCD and neurodegeneration are clearly visible, but not outside of this HS focus. Ventral parts of the ipsilateral DG of iKA mice as well as the contralateral DG may even harbor hyperexcitable GCs (Le Duigou et al., 2008; Young et al., 2009; Häussler et al., 2012).

The molecular mechanism behind the reduced excitability of GCs is mainly transcriptional upregulation of K leak channels, i.e., channels that are open at resting membrane potential (Vrest) (Stegen et al., 2009, 2012; Young et al., 2009). Specifically, these are inwardly rectifying K (Kir) channels of classic leak subtype Kir2.1-4 and two pore domain K leak channels of subtype K2P1.1 and K2P6.1. In addition, elevated tonic chloride (Cl) leak conductances mediated by gamma amino butyric receptors type A (GABAARs) were detected in GCs of iKA mice (Young et al., 2009). Such tonic GABAA currents are likely mediated by extrasynaptic GABAARs composed of α4-6 plus β, and γ2 or δ subunits (Peng et al., 2002; Zhang et al., 2007; Glykys et al., 2008) which could underlie epilepsy-related changes (Peng et al., 2004). In the adult stage, the Cl equilibrium potential (ECl) of GCs is between Vrest and action potential (AP) threshold, although ECl can change during TLE (Palma et al., 2006; Huberfeld et al., 2007; Pathak et al., 2007; Khirug et al., 2010; Barmashenko et al., 2011). Therefore, the functional influence of TLE-related GABAA leak elevation is an enhancement of shunting inhibition. To explain the latter: if a large conductance (1/R) is added, its influence via Ohm's law (U = R × I) will minimize the voltage impact (U) of any further input currents (I). All conductances have this influence, but the counterintuitive effect of “inhibitory depolarization” occurs specifically when E is between Vrest and AP threshold, as with ECl (Staley and Mody, 1992; Wolfart et al., 2005; Meier et al., 2015). There are few but notable differences between the iKA mouse model and the human condition. Human GCs lack the GABAA leak increase and instead show an HS-related enhancement of ZD7288-sensitive, hyperpolarization-activated cation conductance, most likely mediated by HCN1 channels (Stegen et al., 2012). Thus, contrary to prior reports (Stabel et al., 1992), a functional h-current (IH) exists in rodent and human GCs (Young et al., 2009; Stegen et al., 2012) and this IH, as well as respective HCN1 subunits are enhanced in HS-related TLE (Bender et al., 2003; Stegen et al., 2012). The functional effect of IH in GCs is similar to the GABAA leak because EH is also between Vrest and AP threshold, again contributing to enhanced shunting inhibition (Stegen et al., 2012) (see CA Section for more discussion on HCN channels). Another interesting difference between the GCs of TLE patients and iKA mice is that human GCs almost never display a pronounced delay of AP responses as their iKA counterparts (Stegen et al., 2009, 2012; Young et al., 2009). These “ramp” delays of GCs are mediated by shaker-related, voltage-gated K (Kv1) channels containing Kv1.1, Kv1.2, or Kv1.6 subunits, which are sensitive to dendrotoxin and μM concentrations of 4-aminopyridine (4-AP) (Kirchheim et al., 2013). The molecular mechanism for the 3-fold delayed AP responses of iKA GCs is transcriptional upregulation of Kv1.1 subunits, which, consistent with a homeostatic response, is reversible upon interruption of chronic hyperexcitation (Kirchheim et al., 2013). Without these Kv1 currents, GCs are much more vulnerable during excitotoxic insults (Kirchheim et al., 2013). The dissimilarities between human and mouse GCs could be due to species differences or (more likely) due to the disease etiology. However, for the present perspective on AED strategies it is notable that in both human and mouse TLE GCs, a depolarizing but shunting conductance is co-upregulated with Kir channels such that Vrest is almost unchanged (Stegen et al., 2009, 2012; Young et al., 2009). This downscaling is not only suitable to maintain basic metabolic functions dependent on Vrest; it is also a native example of static shunt, enforcing a subtractive gain shift of the neuronal input-output curve (Wolfart et al., 2005). A recent network simulation study has demonstrated that the experimentally observed channel scaling of GCs could also restore spatiotemporal pattern separation under epileptic conditions, i.e., maintain the proposed function of the DG network (Yim et al., 2015).

In addition to the discussed leak channel modifications, other epilepsy-related changes occur in excitatory ion channels and ionotropic receptors of DG cell types (Table 1). For example, voltage-gated Ca (Cav) channels of P/Q-type (Cav2.2) were found increased while the L-type subunit Cav1.2 was diminished in the DG molecular layer of TLE patient vs. autopsy samples (Djamshidian et al., 2002). No such changes were observed in the TLE model of ventricular KA injection (Westenbroek et al., 1998). Many immunohistochemistry studies exist on GABAAR and GABABR changes during TLE: the GABAAR α1-3, β2-3, and γ2 subunits were all found elevated in GCs of TLE patients (Loup et al., 2000) and similar results (except α2) were obtained in the iKA model (Bouilleret et al., 2000; Knuesel et al., 2001). In sPilo, the DG immunostaining of GABAAR subunits is heterogeneous (Brooks-Kayal et al., 1998). Some of the confusion, created by various tissue-level studies was clarified by electron microscopy and functional analysis. For example, Sun et al. (2007) revealed that although GABAA α4 subunits are reduced extrasynaptically in GCs of the hKindl model, they are in fact increased in synaptic locations which was interpreted as proepileptic. Similarly, GABAAγ2 subunits disappear from synaptic locations, reducing the phasic inhibition in sPilo but they reappear in extrasynaptic locations, apparently replacing lost GABAAδ subunits because functionally, tonic inhibition is maintained (Zhang et al., 2007). Measuring surface-coupled protein during sPilo yielded reduction of GABAAβ2/3γ2 subunits on GC membranes; however, GC recordings revealed that tonic GABAA currents were, if anything, increased (Goodkin et al., 2008). In contrast to GABAARs, the GABABR1a-b immunosignal of GCs was found reduced in HS-TLE patients (Munoz et al., 2002).

Interneurons of the DG degenerate in the hilus and the molecular layer but somatic inhibition of GCs is apparently spared (Magloczky and Freund, 2005). Here we refrain from reviewing TLE-related interneuron numbers, as respective cell counting studies mostly rely on Ca binding proteins which themselves change in TLE as shown by Magloczky et al. (1997); for review see Magloczky and Freund (2005). With respect to ion channels of interneurons in the hilus, a decrease of voltage-gated Na type 1 (Nav1) channels (Qiao et al., 2013) and an increase of Cav1 channels (Xu et al., 2007) had been reported. Interestingly, in basket cell interneurons of the DG, tonic GABAA currents are homeostatically adjusted in sPilo rats (Yu et al., 2013).

Astrocytes may also play an important role in epilepsy, in particular via their (potentially impaired) capacity to buffer extracellular K ions (Bordey and Sontheimer, 1998; Jabs et al., 2008; Boison, 2012). For example, in the DG, less glial Kir current was measured in HS- vs. noHS TLE tissue (Hinterkeuser et al., 2000) and less K2P3.1-positive glia was noted in the molecular layer (Kim et al., 2008b). Concerning the Kir channels, it is likely that downregulation of the Kir4.1 subunit is responsible (Buono et al., 2004; Heuser et al., 2012). However, in another sPilo study, no changes of hippocampal Kir4.1 protein were detected or even upregulation was noted in cortical and subcortical regions (Nagao et al., 2013). In a different model (seizure-sensitive gerbils), upregulation of K2P3.1 channels was reported (Kim et al., 2007a). In two human cases, gain of function mutation in the glial Kir4.1 channel was associated with infantile epileptic spasms (Sicca et al., 2011).

In summary, pro- and anticonvulsive channel changes have been described in the DG of different TLE models. For noHS models, it is difficult to draw a final conclusion on channel changes in GCs as these are heterogeneous. In TLE tissue with HS, the ion channel expression of GCs is clearly changed to decreased excitability.

Cornu ammonis

A prominent example of acquired channelopathy is the reduced influence of A-type (rapidly inactivating) K channels in dendrites of CA1 PCs of sPilo rats (Bernard et al., 2004). The respective identification as A-type current was performed in current-clamp experiments via 5 mM 4-AP (Bernard et al., 2004), which blocks delayed rectifier (not rapidly inactivating) Kv1 channels as well as A-type Kv4 and Kv1 channels (Pongs, 1992). In addition, a reduction of Kv4.2 and Kv1.4 mRNA was detected via RT-PCR from microdissected CA1 tissue with mixed cell types (Bernard et al., 2004). The conclusion that Kv4.2 channel downregulation mediated the dendritic channelopathy in sPilo rats (Bernard et al., 2004) was confirmed later by immunocytochemistry, although quantification on the tissue level yielded no difference in the chronic phase (Monaghan et al., 2008). In another sPilo study, Kv4.2 protein of the CA1 region was increased during the first week after SE but decreased in the chronic phase (Su et al., 2008). In the sKA model, Kv4.2 mRNA was reported unchanged in CA1 PCs in the first 24 h but appeared upregulated 12 h later (Francis et al., 1997). In the same model, A-currents of CA1 PCs were decreased but their sensitivity to 50 μM 4-AP and the immunohistochemistry suggested that these currents were rather mediated by Kv1 than Kv4 channels (Sosanya et al., 2014). In contrast to the sPilo rats, tissue from TLE patients with HS displays similar hippocampal Kv4.2 mRNA levels compared to patients without HS, and on the protein level Kv4.2 channels are even elevated, despite the cell loss in the CA1 region (Aronica et al., 2009). In a model of cortical heterotopia, Kv4.2 channels are also elevated in CA1 PCs (Castro et al., 2001). In other epilepsy models, Kv4.2 changes were transient (Tsaur et al., 1992) or increased in the chronic phase (Pei et al., 1997) and also Kv1.2 levels renormalize after the acute phase (Tsaur et al., 1992; Pei et al., 1997). Genetic deletion of Kv4.2 alone is not sufficient to create epilepsy (Hu et al., 2006) which may be due to compensatory mechanisms.

A second prominent channelopathy scenario for TLE also takes place in the distal dendrites of CA1 PCs: downregulation of HCN channels (Bender and Baram, 2007; Dyhrfjeld-Johnsen et al., 2009; Baruscotti et al., 2010; Noam et al., 2011). Opposite to the described increase in DG GCs, HCN1 channels are decreased in CA1 PCs of both sPilo and sKA rats (Jung et al., 2007; Marcelin et al., 2009; Jung et al., 2011). On the tissue level, upregulation of HCN1 was observed in the CA1-3 regions of sPilo, but it was speculated that this staining could have been due to interneurons (Oh et al., 2012). The HCN-mediated ZD7288-sensitive h-current has a shunting effect not only in DG GCs (Stegen et al., 2012) but also in CA1 PCs (Gasparini and Difrancesco, 1997; Magee, 1999; Berger et al., 2001). Consequently, loss of HCN is usually interpreted as proepileptic (Brewster et al., 2002; Poolos et al., 2002; Jung et al., 2007, 2011; Marcelin et al., 2009). However, there are situations, e.g., in febrile seizure models, where an increase of IH in CA1 PCs was interpreted as proepileptic (Chen et al., 2001; Poolos, 2004, 2009; Dyhrfjeld-Johnsen et al., 2008, 2009; Noam et al., 2011). Similar to the A-type channelopathy, the HCN channelopathy of noHS models could so far not be confirmed with human data (Bender et al., 2003). In patients with mild HS, abundant HCN1 protein decorates the distal dendrites of surviving CA1 PCs (Stegen et al., 2012). Similar to Kv4 channels, HCN1 loss in CA1 PCs alone does not produce epilepsy, but it can enhance the susceptibility for certain seizure induction protocols (Huang et al., 2009; Poolos, 2009; Santoro et al., 2010).

Other ion channel modifications in CA1 PCs include an enhanced Cav channel function in the sPilo, determined with 0.1 mM nickel (Sanabria et al., 2001; Su et al., 2002). This concentration inhibits Cav2.3 (R-type) and Cav3 (T-type) channels. The Cav3.2 RNA from homogenized tissue was indeed found elevated in sPilo, but only in the acute phase and not in the chronic phase (Becker et al., 2008). Another sPilo study detected no changes or even downregulation of Cav3 RNA, but also only on the tissue level (Graef et al., 2009). Concerning L-type channels (Cav1.2, Cav1.3), P-type (Cav2.1), N-type channels (Cav2.2), and R-type Cav channels, no immunocytochemistry differences were detected in CA1 PCs of TLE vs. autopsy samples (Djamshidian et al., 2002). Kindled rats displayed an increased window current in CA1 PCs mediated by Nav channels at Vrest (Ketelaars et al., 2001). These differences appeared unlikely to arise from Nav1.1, Nav1.2, and Nav1.6 channels, as their immuno signal was not changed under similar conditions (Blumenfeld et al., 2009). In contrast, a lowered amount of Nav1.2 RNA was found via in situ hybridization in human TLE vs. autopsy samples (Whitaker et al., 2001). Small conductance, Ca-activated K (SK) channels mediating the medium duration afterhyperpolarization (AHP) appeared reduced in CA1 PCs of sPilo rats and this phenomenon corresponded to a reduction of the SK2 RNA amount on the tissue level (Schulz et al., 2012). Another sPilo study found transient changes in SK1 and SK2 protein and permanent downregulation of SK3 via western blotting of homogenized hippocampus (Oliveira et al., 2010). In a maximal electroshock convulsions (MES) model, no changes were detected in Kv1.1/2/4, Kv4.2, and Kir3.1/2 channels of CA1 PCs (Pei et al., 1997). In seizure-sensitive gerbils, CA1 PCs displayed elevated Kv3.1b and Kv3.2 channel immuno signals (Lee et al., 2009).

The PCs of CA2 and CA3 (in particular CA3a/b) are notably less affected by HS-related cell death than CA1 PCs (Wyler et al., 1992; Blümcke et al., 2012). In samples from TLE patients vs. autopsy, CA3 PCs exhibited increased immunoreactivity for Cav2.1 subunits (Djamshidian et al., 2002). In the same work, the Cav1.2 was diminished in CA3 PCs, but enhanced in astrocytes. The Nav1.2 RNA signal was reduced (Whitaker et al., 2001) while the Cav2.1 immuno signal was elevated in CA3 PCs of HS-TLE patients vs. autopsy (Djamshidian et al., 2002). In noHS models, the RNA and immuno intensities of Nav1.6 channels were found raised in CA3 PCs (Blumenfeld et al., 2009) while those of Kv4.2 and Kv1.1 channels were decreased, respectively (Francis et al., 1997; Sosanya et al., 2014). Because chronic Nav upregulation could lead to depolarization block, functional verification is warranted (Auvin et al., 2008; Cestele et al., 2008). The HCN1 RNA was diminished in CA3 PCs of sKA rats, but not after febrile seizures; the HCN2 appeared elevated in both seizure forms, although some of these signals are transient and may be due to interneurons (Brewster et al., 2002). In the MES model, CA cells show little changes in the tested Kv1, Kv4, and Kir3 channels (Pei et al., 1997) while in an absence epilepsy model CA3 PCs displayed upregulation of some Nav channels (Xu et al., 2013b). With respect to HS-related iKA seizures, CA3a/b PCs appear similar to DG GCs, i.e., high Kir2 levels are found in surviving cells (Young et al., 2009). Thus, more functional characterizations of CA3 cell subtypes in relation to different seizure phenotypes are needed. Also, CA interneurons display ion channel changes in TLE. For example, the oriens-lacunosum moleculare interneurons ventral of the HS area in iKA mice possess reduced IH and show increased oscillatory activity in the gamma frequency (Dugladze et al., 2007).

In summary, also in the CA regions, pro- and antiepileptic channel changes have been described in TLE. In comparison with DG GCs, particularly the CA1 PCs stand out with proepileptic changes, as here the two most prominent examples of acquired channelopathy have been described. However, in resected tissue of TLE patients no hyperexcitability was detected in CA1 (Cohen et al., 2002). Thus, the CA1 PC-based acquired channelopathy hypothesis either has to be limited for TLE models without HS or it has to be demonstrated that CA1 PCs in non-sclerotic areas of TLE patients are intrinsically hyperexcitable and/or that surviving hyperexcitable CA1 PCs within the sclerotic hippocampus are connected in a hub-like manner (Morgan and Soltesz, 2008). In its current form, the CA1 PC channelopathy hypothesis collides with the simple principle “dead cells do not seize” (Delorenzo et al., 2005).

Beyond the hippocampus

Although the entorhinal cortex is a likely source of TLE seizures (Spencer and Spencer, 1994; Spencer, 2002), it received less attention compared to the hippocampus. Nevertheless, there is evidence for ion channel alterations in this region. For example, in layer III PCs of sKA rats, the IH was found decreased in the chronic phase although western blot signals of HCN1 and HCN2 channel subunits were at control level at the same time (Shah et al., 2004). In kindled rats, the neocortical layer II stellate cells display elevated Nav currents and Nav1.2/1.6 immunostaining (Hargus et al., 2013). In contrast, a sPilo study found no changes in the intrinsic excitability of layer II PCs and concluded that loss of interneurons was responsible for the elevated perforant path output (Kobayashi et al., 2003). Similarly, Kv1.1 reduction in cortical interneurons could play a role in some forms of TLE (Li et al., 2012). In frontal lobe epilepsy, layer II/III PCs displayed h-current downregulation (Wierschke et al., 2010). In some forms of cortical epilepsies, the opposite of the above described hippocampal Kv4.2 channelopathy occurs; here these channels are upregulated suggesting homeostatic adaptation of cortical neurons (Aronica et al., 2009).

Other brain areas connected to the hippocampus also display epilepsy-related ion channel adaptations or pathologies. For example, in the subiculum, increased Ca currents were detected in sPilo (Wellmer et al., 2002) while in kindling models, the amygdala showed elevated levels of KCNQ2 (Kv7.2) channel protein (Penschuck et al., 2005). Two brain areas rarely implicated in TLE, are the substantia nigra (Depaulis et al., 1994; Ma et al., 2007) and the thalamus (Bertram et al., 2001). One sPilo study found elevated T-type currents in thalamic relay cells and consistent Cav3 channel RNA upregulation on the tissue level (Graef et al., 2009). In contrast, the enhanced Kv4.2 surface protein expression in ventromedial thalamic relay neurons of sPilo argued for an adaptive response (Smith et al., 2012). We use the thalamus to illustrate that similar ion channels can have opposite functions in different cell types and epilepsies: when sufficiently hyperpolarized, thalamic neurons are capable of rebound burst firing which is mediated by T-type (Cav3) channels and thought to underlie absence epilepsy (Budde et al., 2005; Cope et al., 2009; Kanyshkova et al., 2012) although other mechanisms may also play a role (Crunelli and Leresche, 2002; Strauss et al., 2004; Kole et al., 2007). Therefore, it makes sense that absence epilepsy is treated with Cav3 channel inhibitors, while hyperpolarizing AEDs can even aggravate absence seizures (Rogawski and Löscher, 2004; Powell et al., 2014). Bursting of “epileptic neurons” has long been suspected as the cellular correlate of epileptic seizures in general (Sypert and Ward, 1967). Also for TLE, pathological Cav3-supported burst firing has been suggested as a cellular mechanism for seizures (Yaari and Beck, 2002). However, the same T-type channel responsible for epileptic bursting in thalamic and cortical neurons could actually prevent burst firing in other cell types (Wolfart and Roeper, 2002). Hence, it is important to determine the role of AED-targeted ion channels in a cell type-specific manner, in particular since current AEDs are applied systemically.

Mechanisms underlying epilepsy-related ion channel alterations

The molecular upstream links of many of the above described ion channel modifications are unclear. For example, the correlation between HS and the leak channel upregulation in DG GCs currently only allows the statement that some part of the sequence, which leads to HS, must also be responsible for the observed changes in channel transcription. One possibility would be that morphological alterations, e.g., related to cytoskeletal changes as they occur during GCD, directly also cause the channel changes (O'Malley and Harvey, 2007). As GCD is caused by reelin deficiency (Haas et al., 2002), reelin is a candidate molecule and indeed it can affect transcription factors (Feng et al., 1999; Chen et al., 2007). However, the hypothesis requires that reelin deficiency alone (without epilepsy) must also trigger the respective channel changes, which does not appear to be the case (Kowalski et al., 2010). Another possible mechanism for transcriptional channelopathies is that the access to neurotrophic factors is interrupted in areas of injury (Waxman, 2001).

We currently favor the hypothesis that the seizures themselves partially cause HS (Mathern et al., 2002) and that the same seizure-induced mechanisms which cause HS, also cause the ion channel changes. The reasoning is as follows. In animal models, SE-related excitotoxic neurodegeneration has two phases: an acute glutamate receptor overstimulation cell swelling phase, and a late Ca-related phase, which gradually fades into the chronic phase of spontaneous seizures, the latter being associated with permanently disturbed intracellular Ca levels (Olney and Sharpe, 1969; Choi, 1992; Magloczky and Freund, 1995; Delorenzo et al., 2005). Also for the iKA model two phases of HS have been described; in the first phase, i.e., hours after KA injection, CA1 PCs and hilar neurons degenerate; in the second phase, about 2 weeks after KA injection, full HS develops with GCD and neurodegeneration affecting CA1, CA3c PCs and eventually also CA3a/b, CA2 PCs, and DG GCs (Bouilleret et al., 1999). While the initial injury has its own channel changes (see below), the second phase of HS-related neurodegeneration in iKA mice correlates well with the described downscaling GC excitability in the same model (Young et al., 2009). Another argument for the hypothesis “chronic seizures cause chronic channel adaptations” is the evidence showing that activity-dependent Ca signals directly couple the degree of excitation to the regulation of gene expression (Marder and Goaillard, 2006). Furthermore, hippocampal seizures are associated with extensive NMDA receptor activation and Ca influx inducing cell stress and neurodegeneration (Isokawa and Levesque, 1991; Magloczky and Freund, 1995; Golowasch et al., 1999; Limbrick et al., 2003; Raza et al., 2004; Ayala and Tapia, 2005; Suzuki et al., 2005). From what we know about the mechanisms of long term synaptic potentiation (LTP), the NMDA-mediated Ca-influx during seizures is likely to activate Ca-dependent kinases (Varga et al., 2004; Nassirpour et al., 2010) and transcription factors, which in turn regulate the transcription of specific ion channel genes (Scharfman, 2002; Fan et al., 2005; Blair et al., 2008; Mucha et al., 2010). This view is also consistent with many homeostasis studies demonstrating how increased neuronal activity can directly influence ion channel expression (Turrigiano et al., 1995; Desai et al., 1999; Van Welie et al., 2004; Misonou et al., 2006). Even the subunit-specific heteromerization can be influenced by seizure-like activity (Zha et al., 2008). Another aspect of epilepsy-related channel regulation is the subject of age. Generally, the immature brain appears more sensitive to seizures than the adult brain (Jensen and Baram, 2000), but chronic epilepsy may develop easier in adult animals (Brooks-Kayal et al., 1998; Zhang et al., 2004; Raol et al., 2006b).

Many mechanistic questions remain. For example: if TLE models without HS show similar elevated input to GCs as HS models (Kobayashi et al., 2003; Kumar and Buckmaster, 2006), why do they not display the same channel changes as HS-TLE models? We would like to know what kind of patterns evoke which type of homeostatic ion channel regulation. There are many molecules modified in HS-related TLE (Becker et al., 2003; Elliott et al., 2003; Lukasiuk and Pitkanen, 2004; Motti et al., 2010; Okamoto et al., 2010). Which of these molecules relates to ion channel transformations? A major question is: if the hypothesis of activity- and Ca-dependent homeostatic channel regulation is true, why are there so few adaptive changes in CA1 PCs (Whitaker et al., 2001; Ge et al., 2011)? One possibility would be that CA PCs have a network task that does not allow such homeostatic adaptations. For example, if activity-dependent LTP strengthens synapses on CA1 PCs, it could be counterproductive if the same activity would weaken synaptic impact. In this context, it makes sense that LTP-inducing mechanisms are accompanied by permissive Kv channel internalization (Kim et al., 2007b; Hyun et al., 2013) or HCN1 downregulation (Mcclelland et al., 2011). On the other hand, it is unlikely that LTP of CA1 PCs is a positive feedback mechanism that exists without homeostatic ion channel control (Abbott and Nelson, 2000). Astonishingly, the survival rate of CA1 PC cells is even higher in the noHS TLE models where exactly these detrimental mechanisms have been discovered. If noHS TLE would be an early stage of HS TLE, the LTP-permissive channel regulation of CA1 PCs could be even stronger in HS-related TLE and in fact be responsible for the CA1 PC degeneration. Back to the initial question: CA1 PCs are indeed also capable of homeostatic ion channel regulation counteracting chronic hyperexcitability (Van Welie et al., 2004, 2006; Otto et al., 2006). Thus, similar to the interaction of LTP and synaptic depression, there must be mechanisms to separate homeostatic and LTP-permissive ion channel regulation within the same neuron.

In addition to the control of gene transcription, epilepsy-related changes in ion channel function can be fine-tuned via post-transcriptional mechanisms like splicing and RNA edition, as well as oxidation or phosphorylation. For example, glycine receptors of hippocampi resected from TLE patients show altered RNA editing, which is particularly relevant when combined with abnormal expression of Cl cotransporter 2 (KCC2) and proconvulsive shift of ECl (Eichler et al., 2008; Meier et al., 2014). Another example is the increased Kv1.1 RNA editing found in sKA rats (Streit et al., 2011). The intracellular redox state is also known to influence ion channel function via post-translational modulation (Ruppersberg et al., 1991) and redox-sensitivity of A-type channels appears to be modified in DG GCs from sPilo rats (Rüschenschmidt et al., 2006). Hypoxia is another stimulus for adaptive ion channel modification. For example, in CA1 PCs, reduced oxygen levels lead to IH downregulation within less than an hour (Zhang et al., 2006). Seizure-related pH changes can also affect channel function and vice versa (Ziemann et al., 2008). Furthermore, phosphorylation is a cellular mechanism, not only to regulate protein trafficking but also to dynamically control ion channel gating (Levitan, 1994). For example, the above discussed (sKA Kv4 and sPilo HCN) channelopathies had both been linked to the intracellular phosphorylation status (Lugo et al., 2008; Jung et al., 2010). Finally, reciprocal changes in phosphorylation and methylation of Nav channels had been observed with sKA-related seizures (Baek et al., 2014).

Ion channel function depends on the subcellular location to which the channels are targeted and this targeting can be altered in epilepsy (Chung et al., 2006). One example is the subcellular redistribution of dendritic Kv4.2 channels in sPilo rats from the inner to the outer molecular layer of the DG (Monaghan et al., 2008). Another example is the disturbed HCN channel trafficking into dendrites of CA1 PCs in epilepsy models (Shin et al., 2008). Furthermore, the axon initial segment and presynaptic terminals have been specifically implicated in TLE (Wimmer et al., 2010; Meier et al., 2014). Thus, ion channels are constantly adapted on pre- and post-translational levels and epilepsy interferes with both levels. Nevertheless, it may be possible to separate the channel changes into those which are part of a cure, i.e., homeostatic in nature, and those which are part of the disease, i.e., either straightforward channelopathy or failure of homeostasis. In any case, AEDs must act on the background of these channel changes. In the next chapter we ask which AEDs have mechanisms of actions comparable to the homeostatic channel regulations observed in neurons during TLE.

Ion channel-related antiepileptic drug and gene therapy mechanisms

The available AEDs are hypothesized to work via reducing the impact of excitatory ion channels and/or increasing the effect of net inhibitory channels (Löscher et al., 2013). For example, Phenytoin, Carbamazepine, Lamotrigine, Oxcarbazepine, Zonisamide, Rufinamide, Lacosamide, and Eslicarbazepine are thought to act via Na channels, whereas Ethosuximide, Gabapentin, Pregabalin are Ca channel antagonists. Phenobarbital, Primidone, Diazepam, Clonazepam, Clobazam, Progabide, Vigabatrin, and Tiagabin support inhibition via GABAA channels. Other AEDs like Valproate, Felbamate, and Topiramate are effective at multiple of the above targets. There is only one K channel enhancer AED on the market: the recently approved, first-in-class AED Retigabine (Faulkner and Burke, 2013). Thus, current AEDs mainly target excitatory channels while in contrast, the neurons frequently upregulate K channels when faced with epileptic hyperexcitability (Table 1). Despite the dissimilar routes of AED mechanisms and cell type-specific homeostasis, some of the cellular strategies are indeed comparable to (potential) AED mechanisms (Table 2). More than 100 K channel subunits are currently known (Coetzee et al., 1999; Goldstein et al., 2005; Gutman et al., 2005; Kubo et al., 2005; Wei et al., 2005) and interaction of native subunits enlarges the number of K currents that can be considered as potential AED targets in preclinical research considerably. Therefore, we propose that cell type-specific approaches based on endogenous homeostasis mechanisms, could guide target-driven development of AEDs.

Early studies investigated ATP-sensitive Kir (Kir6) channel openers such as cromakalim and diazoxide as potential AEDs (Alzheimer and Ten Bruggencate, 1988; Gandolfo et al., 1989a,b). These Kir6 channel enhancers were also found protective in anoxia-induced seizures (Mattia et al., 1994; Yamada et al., 2001). However, because Kir6 channels are also expressed in the periphery and because the substances were ineffective in standard AED testing models, Kir6 channel activators may be of limited utility for epilepsy therapy (Wickenden, 2002; Meldrum and Rogawski, 2007). Systemic administration of SK channel enhancer EBIO reduces seizures in certain seizure models but also produced severe adverse effects (Anderson et al., 2006). Also, Cl channels were considered in the context of TLE (Stogmann et al., 2006; Bertelli et al., 2007; Rinke et al., 2010). Retigabine was initially thought to exert its anticonvulsive action only via GABARs (Rostock et al., 1996; Otto et al., 2002). Later it was shown that Retigabine also activates Kv7 channels, fortunately those of the brain (Kv7.2-5) and not those of the heart (Kv7.1) raising hopes on the new AED class (Main et al., 2000; Rundfeldt and Netzer, 2000; Wickenden et al., 2000; Tatulian et al., 2001; Dost et al., 2004). However, to establish how retigabine and similar related compounds are best used in epilepsy therapy, still has to be determined (Splinter, 2013).

The Kv1.1 channel subunit has often been implicated in epilepsy (Smart et al., 1998; Wenzel et al., 2007; Robbins and Tempel, 2012). A gene therapy approach showed that viral Kv1.1 overexpression in neocortical PCs of mice with neocortical epilepsy, effectively reduces the respective seizures (Wykes et al., 2012). A Kv1.1 reduction in interneurons was also suggested to play a role in some forms of TLE (Li et al., 2012). Interestingly, precisely the Kv1.1 subunits are enhanced endogenously in DG GCs of iKA mice with severe HS (Kirchheim et al., 2013) but apparently not in TLE patients with HS (Stegen et al., 2009, 2012). Thus, Kv1.1 enhancement in specific hippocampal neurons could be an excellent antiepileptic and neuroprotective strategy (Kirchheim et al., 2013; Sosanya et al., 2014).

A number of drugs, originally approved for a different action, were later found to enhance Kir channel function; e.g., Kir1.1 (Pregabaline) and Kir2.3 (Tenidap; Liu et al., 2002; Lee and Liou, 2014). Furthermore, supporting Kir3 channel (Kaufmann et al., 2013) and Kir2 channel (Xu et al., 2013a) function in vivo is effective against seizures of certain epilepsy models (Table 2). Finally, K2P2.1 upregulation via adenoviral gene therapy reduces EEG seizures in the sPilo model (Dey et al., 2014). Hence, leak K channels could be an attractive AED target. Again, especially Kir2.1-2.4 and K2P2.1 leak channels, which are endogenously upregulated in DG GCs during epileptic hyperexcitability, appear to be good candidates (Young et al., 2009).

Although enhancing K channel function is a plausible antiepileptic strategy, there are drawbacks. For example, too much silencing via K channels can also be detrimental (Du et al., 2005; Taverna et al., 2005; Coulson et al., 2008). Furthermore, as discussed for the thalamus, de-inactivation of Nav and Cav channels necessary for AP activation results in the counterintuitive effect that enhancing K currents can increase seizure susceptibility. One example is the big conductance, Ca-activated K (BK) channel. These channels contribute to the fast AHP, enabling high AP frequencies. Consequently, enhancing BK currents has proepileptic effects (Jin et al., 2000; Brenner et al., 2005; Shruti et al., 2008). If in turn the fast AHP is impaired in interneurons, e.g., via loss of Kv3.2 channels, seizures become more likely (Lau et al., 2000). Hence, the usability of K channel enhancing AEDs has to be carefully evaluated.

As explained, certain Cl and cation conductances, mediated by GABAARs and HCN channels, confer shunting inhibition which may also be used as an AED strategy. Indeed, enhancing tonic GABAA currents by overexpression of α5/β3/γ2 and α6/β3/δGABARs, reduced epileptiform activity in hippocampal cell culture and elevation of the δ GABARs in vivo lowered cyclothiazide (CTZ)-induced seizures (Sun et al., 2013). Also HCN channels are an AED target which requires further investigation (Poolos et al., 2002; Shah et al., 2013): certain AEDs, initially approved as Nav and Cav channel blockers, later turned out be enhancers of IH in CA1 PCs as well (Poolos et al., 2002; Surges et al., 2003). However, since one of them (Lamotrigine) was also effective in interneurons (Peng et al., 2010), further experiments must clarify to which extend IH is involved in the mechanisms of action of these AEDs. As explained above, the combination of Kir and HCN/Cl channel upregulation achieves a homeostatic shunt in GCs during TLE (Young et al., 2009; Stegen et al., 2012). It is tempting to speculate that support of such shunting channel combinations indicated by GCs (which could be called “channelacoids”) is a particularly promising AED strategy.

Impaired interneuron activity, e.g., due to Nav channel mutations, often increases seizure susceptibility (Lau et al., 2000; Chen et al., 2002; Ogiwara et al., 2007; Martin et al., 2010; Mashimo et al., 2010; Rossignol et al., 2013; De Kovel et al., 2014; Hedrich et al., 2014). Therefore, it makes sense that supporting GABAergic transmission is a successful AED treatment (see above). However, more cell type-specific data is needed to explain how systemically administered AEDs, which block Nav channels also expressed in interneurons, actually work. Apparently these AEDs preferentially target excitatory neurons (Prakriya and Mennerick, 2000; He et al., 2002; Pothmann et al., 2014). On the other hand, functional enhancement of interneurons can be an effective AED strategy (Jensen et al., 2014). The next question would be how interneurons inhibiting interneurons fit into these scenarios (Kim et al., 2008a). Generally, the specific role of interneuron subtypes in epilepsy is far from clear, in particular when considering that many of the synchronous AP rhythms, generated by interneurons, are suspiciously akin to epileptic seizures (Cobb et al., 1995; Cohen et al., 2002; D'antuono et al., 2004; Vida et al., 2006). Last but not least, it should be kept in mind that all ion channel abnormalities acquired during epilepsy, can affect their sensitivity for AEDs. Indeed, changes in the channel subunit composition are among the mechanisms proposed to underlie acquired pharmacoresistance (Sun et al., 2007; Zhang et al., 2007; Streit et al., 2011). One example would be a decrease of the Kv7.2/7.3 ratio, as suggested by (Otto et al., 2006), which is expected to increase the Retigabine sensitivity of Kv7 channels (Schenzer et al., 2005).

In summary, cell type-specific information on epilepsy-related ion channel modifications can explain and support AED strategies. Precisely those inhibitory ion channels which appear to be effective AED targets in preclinical tests are the ones upregulated in DG GCs during TLE. These data indicate that cell-endogenous ion channel homeostasis mechanisms could be used as “channelacoid” archetypes in the search of antiepileptic strategies. In particular, the enhancement of static shunt via combined K/Cl/cation leak channel support appears to be a promising strategy.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Statements

Acknowledgments

JW and DL were/are funded via the grants SFB780/C2 and WO1563/1-1 of the Deutsche Forschungsgemeinschaft (DFG), respectively.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  • 1

    Abbott L. F. Nelson S. B. (2000). Synaptic plasticity: taming the beast. Nat. Neurosci. 3(Suppl.), 11781183. 10.1038/81453

  • 2

    Alzheimer C. Ten Bruggencate G. (1988). Actions of BRL 34915 (Cromakalim) upon convulsive discharges in guinea pig hippocampal slices. Naunyn Schmiedebergs. Arch. Pharmacol. 337, 429434. 10.1007/BF00169535

  • 3

    Anderson N. J. Slough S. Watson W. P. (2006). In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant. Eur. J. Pharmacol. 546, 4853. 10.1016/j.ejphar.2006.07.007

  • 4

    Aronica E. Boer K. Doorn K. J. Zurolo E. Spliet W. G. Van Rijen P. C. et al . (2009). Expression and localization of voltage dependent potassium channel Kv4.2 in epilepsy associated focal lesions. Neurobiol. Dis. 36, 8195. 10.1016/j.nbd.2009.06.016

  • 5

    Auvin S. Dulac O. Vallee L. (2008). Do SCN1A mutations protect from hippocampal sclerosis?Epilepsia49, 11071108. 10.1111/j.1528-1167.2008.01549_3.x

  • 6

    Ayala G. X. Tapia R. (2005). Late N-methyl-D-aspartate receptor blockade rescues hippocampal neurons from excitotoxic stress and death after 4-aminopyridine-induced epilepsy. Eur. J. Neurosci. 22, 30673076. 10.1111/j.1460-9568.2005.04509.x

  • 7

    Baek J. H. Rubinstein M. Scheuer T. Trimmer J. S. (2014). Reciprocal changes in phosphorylation and methylation of mammalian brain sodium channels in response to seizures. J. Biol. Chem. 289, 1536315373. 10.1074/jbc.M114.562785

  • 8

    Barmashenko G. Hefft S. Aertsen A. Kirschstein T. Köhling R. (2011). Positive shifts of the GABA(A) receptor reversal potential due to altered chloride homeostasis is widespread after status epilepticus. Epilepsia52, 15701578. 10.1111/j.1528-1167.2011.03247.x

  • 9

    Bartolomei F. Gastaldi M. Massacrier A. Planells R. Nicolas S. Cau P. (1997). Changes in the mRNAs encoding subtypes I, II and III sodium channel alpha subunits following kainate-induced seizures in rat brain. J. Neurocytol. 26, 667678. 10.1023/A:1018549928277

  • 10

    Baruscotti M. Bottelli G. Milanesi R. Difrancesco J. C. Difrancesco D. (2010). HCN-related channelopathies. Pflugers Arch. 460, 405415. 10.1007/s00424-010-0810-8

  • 11

    Beck H. Blumcke I. Kral T. Clusmann H. Schramm J. Wiestler O. D. et al . (1996). Properties of a delayed rectifier potassium current in dentate granule cells isolated from the hippocampus of patients with chronic temporal lobe epilepsy. Epilepsia37, 892901. 10.1111/j.1528-1157.1996.tb00043.x

  • 12

    Beck H. Steffens R. Elger C. E. Heinemann U. (1998). Voltage-dependent Ca2+ currents in epilepsy. Epilepsy Res. 32, 321332. 10.1016/S0920-1211(98)00062-X

  • 13

    Beck H. Yaari Y. (2008). Plasticity of intrinsic neuronal properties in CNS disorders. Nat. Rev. Neurosci. 9, 357369. 10.1038/nrn2371

  • 14

    Becker A. J. Chen J. Zien A. Sochivko D. Normann S. Schramm J. et al . (2003). Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 18, 27922802. 10.1111/j.1460-9568.2003.02993.x

  • 15

    Becker A. J. Pitsch J. Sochivko D. Opitz T. Staniek M. Chen C. C. et al . (2008). Transcriptional upregulation of Cav3.2 mediates epileptogenesis in the pilocarpine model of epilepsy. J. Neurosci. 28, 1334113353. 10.1523/JNEUROSCI.1421-08.2008

  • 16

    Ben-Ari Y. (1985). Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience14, 375403. 10.1016/0306-4522(85)90299-4

  • 17

    Ben-Ari Y. (2008). Epilepsies and neuronal plasticity: for better or for worse?Dialogues Clin. Neurosci. 10, 1727.

  • 18

    Bender R. A. Baram T. Z. (2007). Epileptogenesis in the developing brain: what can we learn from animal models?Epilepsia48(Suppl. 5), 26. 10.1111/j.1528-1167.2007.01281.x

  • 19

    Bender R. A. Soleymani S. V. Brewster A. L. Nguyen S. T. Beck H. Mathern G. W. et al . (2003). Enhanced expression of a specific hyperpolarization-activated cyclic nucleotide-gated cation channel (HCN) in surviving dentate gyrus granule cells of human and experimental epileptic hippocampus. J. Neurosci. 23, 68266836.

  • 20

    Berger T. Larkum M. E. Luscher H. R. (2001). High I(h) channel density in the distal apical dendrite of layer V pyramidal cells increases bidirectional attenuation of EPSPs. J. Neurophysiol. 85, 855868.

  • 21

    Bernard C. Anderson A. Becker A. Poolos N. P. Beck H. Johnston D. (2004). Acquired dendritic channelopathy in temporal lobe epilepsy. Science305, 532535. 10.1126/science.1097065

  • 22

    Bertelli M. Cecchin S. Lapucci C. De Gemmis P. Danieli D. D'Amore E. S. et al . (2007). Quantification of chloride channel 2 (CLCN2) gene isoforms in normal versus lesion- and epilepsy-associated brain tissue. Biochim. Biophys. Acta1772, 1520. 10.1016/j.bbadis.2006.10.015

  • 23

    Bertram E. H. Mangan P. S. Zhang D. Scott C. A. Williamson J. M. (2001). The midline thalamus: alterations and a potential role in limbic epilepsy. Epilepsia42, 967978. 10.1046/j.1528-1157.2001.042008967.x

  • 24

    Biervert C. Schroeder B. C. Kubisch C. Berkovic S. F. Propping P. Jentsch T. J. et al . (1998). A potassium channel mutation in neonatal human epilepsy. Science279, 403406. 10.1126/science.279.5349.403

  • 25

    Blair R. E. Sombati S. Churn S. B. Delorenzo R. J. (2008). Epileptogenesis causes an N-methyl-d-aspartate receptor/Ca2+-dependent decrease in Ca2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneous recurrent epileptiform discharges. Eur. J. Pharmacol. 588, 6471. 10.1016/j.ejphar.2008.04.021

  • 26

    Blümcke I. Coras R. Miyata H. Ozkara C. (2012). Defining clinico-neuropathological subtypes of mesial temporal lobe epilepsy with hippocampal sclerosis. Brain Pathol. 22, 402411. 10.1111/j.1750-3639.2012.00583.x

  • 27

    Blümcke I. Thom M. Aronica E. Armstrong D. D. Bartolomei F. Bernasconi A. et al . (2013). International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia54, 13151329. 10.1111/epi.12220

  • 28

    Blümcke I. Thom M. Wiestler O. D. (2002). Ammon's horn sclerosis: a maldevelopmental disorder associated with temporal lobe epilepsy. Brain Pathol. 12, 199211.

  • 29

    Blumenfeld H. Lampert A. Klein J. P. Mission J. Chen M. C. Rivera M. et al . (2009). Role of hippocampal sodium channel Nav1.6 in kindling epileptogenesis. Epilepsia50, 4455. 10.1111/j.1528-1167.2008.01710.x

  • 30

    Blumenfeld H. Meador K. J. (2014). Consciousness as a useful concept in epilepsy classification. Epilepsia55, 11451150. 10.1111/epi.12588

  • 31

    Boison D. (2012). Adenosine dysfunction in epilepsy. Glia60, 12341243. 10.1002/glia.22285

  • 32

    Bordey A. Sontheimer H. (1998). Properties of human glial cells associated with epileptic seizure foci. Epilepsy Res. 32, 286303. 10.1016/S0920-1211(98)00059-X

  • 33

    Bouilleret V. Loup F. Kiener T. Marescaux C. Fritschy J. M. (2000). Early loss of interneurons and delayed subunit-specific changes in GABA(A)-receptor expression in a mouse model of mesial temporal lobe epilepsy. Hippocampus10, 305324. 10.1002/1098-1063(2000)10:3<305::AID-HIPO11>3.0.CO;2-I

  • 34

    Bouilleret V. Ridoux V. Depaulis A. Marescaux C. Nehlig A. Le Gal La Salle G. (1999). Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience89, 717729. 10.1016/S0306-4522(98)00401-1

  • 35

    Brenner R. Chen Q. H. Vilaythong A. Toney G. M. Noebels J. L. Aldrich R. W. (2005). BK channel beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat. Neurosci. 8, 17521759. 10.1038/nn1573

  • 36

    Brewster A. Bender R. A. Chen Y. Dube C. Eghbal-Ahmadi M. Baram T. Z. (2002). Developmental febrile seizures modulate hippocampal gene expression of hyperpolarization-activated channels in an isoform- and cell-specific manner. J. Neurosci. 22, 45914599.

  • 37

    Briellmann R. S. Mark Wellard R. Masterton R. A. Abbott D. F. Berkovic S. F. Jackson G. D. (2007). Hippocampal sclerosis: MR prediction of seizure intractability. Epilepsia48, 315323. 10.1111/j.1528-1167.2006.00932.x

  • 38

    Brooks-Kayal A. R. Shumate M. D. Jin H. Rikhter T. Y. Coulter D. A. (1998). Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat. Med. 4, 11661172. 10.1038/2661

  • 39

    Budde T. Caputi L. Kanyshkova T. Staak R. Abrahamczik C. Munsch T. et al . (2005). Impaired regulation of thalamic pacemaker channels through an imbalance of subunit expression in absence epilepsy. J. Neurosci. 25, 98719882. 10.1523/JNEUROSCI.2590-05.2005

  • 40

    Bumanglag A. V. Sloviter R. S. (2008). Minimal latency to hippocampal epileptogenesis and clinical epilepsy after perforant pathway stimulation-induced status epilepticus in awake rats. J. Comp. Neurol. 510, 561580. 10.1002/cne.21801

  • 41

    Buono R. J. Lohoff F. W. Sander T. Sperling M. R. O'Connor M. J. Dlugos D. J. et al . (2004). Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility. Epilepsy Res. 58, 175183. 10.1016/j.eplepsyres.2004.02.003

  • 42

    Castro P. A. Cooper E. C. Lowenstein D. H. Baraban S. C. (2001). Hippocampal heterotopia lack functional Kv4.2 potassium channels in the methylazoxymethanol model of cortical malformations and epilepsy. J. Neurosci. 21, 66266634.

  • 43

    Cavalleri G. L. Weale M. E. Shianna K. V. Singh R. Lynch J. M. Grinton B. et al . (2007). Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol. 6, 970980. 10.1016/S1474-4422(07)70247-8

  • 44

    Cestele S. Scalmani P. Rusconi R. Terragni B. Franceschetti S. Mantegazza M. (2008). Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+ channel. J. Neurosci. 28, 72737283. 10.1523/JNEUROSCI.4453-07.2008

  • 45

    Charlier C. Singh N. A. Ryan S. G. Lewis T. B. Reus B. E. Leach R. J. et al . (1998). A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 18, 5355. 10.1038/ng098-53

  • 46

    Chen C. Bharucha V. Chen Y. Westenbroek R. E. Brown A. Malhotra J. D. et al . (2002). Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc. Natl. Acad. Sci. U.S.A. 99, 1707217077. 10.1073/pnas.212638099

  • 47

    Chen K. Aradi I. Thon N. Eghbal-Ahmadi M. Baram T. Z. Soltesz I. (2001). Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat. Med. 7, 331337. 10.1038/85480

  • 48

    Chen Y. Kundakovic M. Agis-Balboa R. C. Pinna G. Grayson D. R. (2007). Induction of the reelin promoter by retinoic acid is mediated by Sp1. J. Neurochem. 103, 650665. 10.1111/j.1471-4159.2007.04797.x

  • 49

    Chioza B. Osei-Lah A. Wilkie H. Nashef L. McCormick D. Asherson P. et al . (2002). Suggestive evidence for association of two potassium channel genes with different idiopathic generalised epilepsy syndromes. Epilepsy Res. 52, 107116. 10.1016/S0920-1211(02)00195-X

  • 50

    Choi D. W. (1992). Excitotoxic cell death. J. Neurobiol. 23, 12611276. 10.1002/neu.480230915

  • 51

    Chung H. J. Jan Y. N. Jan L. Y. (2006). Polarized axonal surface expression of neuronal KCNQ channels is mediated by multiple signals in the KCNQ2 and KCNQ3 C-terminal domains. Proc. Natl. Acad. Sci. U.S.A. 103, 88708875. 10.1073/pnas.0603376103

  • 52

    Cobb S. R. Buhl E. H. Halasy K. Paulsen O. Somogyi P. (1995). Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature378, 7578. 10.1038/378075a0

  • 53

    Coetzee W. A. Amarillo Y. Chiu J. Chow A. Lau D. Mccormack T. et al . (1999). Molecular diversity of K+ channels. Ann. N.Y. Acad. Sci. 868, 233285. 10.1111/j.1749-6632.1999.tb11293.x

  • 54

    Cohen I. Navarro V. Clemenceau S. Baulac M. Miles R. (2002). On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science298, 14181421. 10.1126/science.1076510

  • 55

    Coleman N. Nguyen H. M. Cao Z. Brown B. M. Jenkins D. P. Zolkowska D. et al . (2015). The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed K2 Activator and na blocker, is a potent novel anticonvulsant. Neurotherapeutics12, 234249. 10.1007/s13311-014-0305-y

  • 56

    Cope D. W. Di Giovanni G. Fyson S. J. Orban G. Errington A. C. Lorincz M. L. et al . (2009). Enhanced tonic GABAA inhibition in typical absence epilepsy. Nat. Med. 15, 13921398. 10.1038/nm.2058

  • 57

    Coulson E. J. May L. M. Osborne S. L. Reid K. Underwood C. K. Meunier F. A. et al . (2008). p75 neurotrophin receptor mediates neuronal cell death by activating GIRK channels through phosphatidylinositol 4,5-bisphosphate. J. Neurosci. 28, 315324. 10.1523/JNEUROSCI.2699-07.2008

  • 58

    Coulter D. A. (2000). Mossy fiber zinc and temporal lobe epilepsy: pathological association with altered “epileptic” gamma-aminobutyric acid A receptors in dentate granule cells. Epilepsia41(Suppl. 6), S96S99. 10.1111/j.1528-1157.2000.tb01565.x

  • 59

    Coulter D. A. Mcintyre D. C. Löscher W. (2002). Animal models of limbic epilepsies: what can they tell us?Brain Pathol. 12, 240256. 10.1111/j.1750-3639.2002.tb00439.x

  • 60

    Crunelli V. Leresche N. (2002). Block of thalamic T-Type Ca(2+) channels by ethosuximide is not the whole story. Epilepsy Curr. 2, 5356. 10.1046/j.1535-7597.2002.00024.x

  • 61

    Curia G. Lucchi C. Vinet J. Gualtieri F. Marinelli C. Torsello A. et al . (2014). Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic?Curr. Med. Chem. 21, 663688. 10.2174/0929867320666131119152201

  • 62

    D'adamo M. C. Catacuzzeno L. Di Giovanni G. Franciolini F. Pessia M. (2013). K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy. Front. Cell. Neurosci. 7:134. 10.3389/fncel.2013.00134

  • 63

    D'antuono M. Louvel J. Köhling R. Mattia D. Bernasconi A. Olivier A. et al . (2004). GABAA receptor-dependent synchronization leads to ictogenesis in the human dysplastic cortex. Brain127, 16261640. 10.1093/brain/awh181

  • 64

    Danielsson B. R. Lansdell K. Patmore L. Tomson T. (2003). Phenytoin and phenobarbital inhibit human HERG potassium channels. Epilepsy Res. 55, 147157. 10.1016/S0920-1211(03)00119-0

  • 65

    Danielsson B. R. Lansdell K. Patmore L. Tomson T. (2005). Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents. Epilepsy Res. 63, 1725. 10.1016/j.eplepsyres.2004.10.002

  • 66

    Davis G. W. Bezprozvanny I. (2001). Maintaining the stability of neural function: a homeostatic hypothesis. Annu. Rev. Physiol. 63, 847869. 10.1146/annurev.physiol.63.1.847

  • 67

    De Kovel C. G. Meisler M. H. Brilstra E. H. Van Berkestijn F. M. Van 'T Slot R. Van Lieshout S. et al . (2014). Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy. Epilepsy Res. 108, 15111518. 10.1016/j.eplepsyres.2014.08.020

  • 68

    De Lanerolle N. C. Brines M. Williamson A. Kim J. H. Spencer D. D. (1992). Neurotransmitters and their receptors in human temporal lobe epilepsy. Epilepsy Res. Suppl. 7, 235250.

  • 69

    De Lanerolle N. C. Kim J. H. Williamson A. Spencer S. S. Zaveri H. P. Eid T. et al . (2003). A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia44, 677687. 10.1046/j.1528-1157.2003.32701.x

  • 70

    De Lanerolle N. C. Lee T. S. (2005). New facets of the neuropathology and molecular profile of human temporal lobe epilepsy. Epilepsy Behav. 7, 190203. 10.1016/j.yebeh.2005.06.003

  • 71

    De Tisi J. Bell G. S. Peacock J. L. Mcevoy A. W. Harkness W. F. Sander J. W. et al . (2011). The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet378, 13881395. 10.1016/S0140-6736(11)60890-8

  • 72

    Delorenzo R. J. Sun D. A. Deshpande L. S. (2005). Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol. Ther. 105, 229266. 10.1016/j.pharmthera.2004.10.004

  • 73

    Depaulis A. Vergnes M. Marescaux C. (1994). Endogenous control of epilepsy: the nigral inhibitory system. Prog. Neurobiol. 42, 3352. 10.1016/0301-0082(94)90020-5

  • 74

    Desai N. S. Rutherford L. C. Turrigiano G. G. (1999). Plasticity in the intrinsic excitability of cortical pyramidal neurons. Nat. Neurosci. 2, 515520. 10.1038/9165

  • 75

    Dey D. Eckle V. S. Vitko I. Sullivan K. A. Lasiecka Z. M. Winckler B. et al . (2014). A potassium leak channel silences hyperactive neurons and ameliorates status epilepticus. Epilepsia55, 203213. 10.1111/epi.12472

  • 76

    Dietrich D. Clusmann H. Kral T. Steinhauser C. Blumcke I. Heinemann U. et al . (1999). Two electrophysiologically distinct types of granule cells in epileptic human hippocampus. Neuroscience90, 11971206. 10.1016/S0306-4522(98)00574-0

  • 77

    Dietrich D. Podlogar M. Ortmanns G. Clusmann H. Kral T. (2005). Calbindin-D28k content and firing pattern of hippocampal granule cells in amygdala-kindled rats: a perforated patch-clamp study. Brain Res. 1032, 123130. 10.1016/j.brainres.2004.10.060

  • 78

    Djamshidian A. Grassl R. Seltenhammer M. Czech T. Baumgartner C. Schmidbauer M. et al . (2002). Altered expression of voltage-dependent calcium channel alpha(1) subunits in temporal lobe epilepsy with Ammon's horn sclerosis. Neuroscience111, 5769. 10.1016/S0306-4522(01)00528-0

  • 79

    Dost R. Rostock A. Rundfeldt C. (2004). The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn Schmiedebergs. Arch. Pharmacol. 369, 382390. 10.1007/s00210-004-0881-1

  • 80

    Du W. Bautista J. F. Yang H. Diez-Sampedro A. You S. A. Wang L. et al . (2005). Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat. Genet. 37, 733738. 10.1038/ng1585

  • 81

    Dugladze T. Vida I. Tort A. B. Gross A. Otahal J. Heinemann U. et al . (2007). Impaired hippocampal rhythmogenesis in a mouse model of mesial temporal lobe epilepsy. Proc. Natl. Acad. Sci. U.S.A. 104, 1753017535. 10.1073/pnas.0708301104

  • 82

    Dyhrfjeld-Johnsen J. Morgan R. J. Foldy C. Soltesz I. (2008). Upregulated H-Current in Hyperexcitable CA1 Dendrites after Febrile Seizures. Front. Cell. Neurosci. 2:2. 10.3389/neuro.03.002.2008

  • 83

    Dyhrfjeld-Johnsen J. Morgan R. J. Soltesz I. (2009). Double trouble? potential for hyperexcitability following both channelopathic up- and downregulation of I(h) in epilepsy. Front. Neurosci. 3, 2533. 10.3389/neuro.01.005.2009

  • 84

    Eichler S. A. Kirischuk S. Juttner R. Schaefermeier P. K. Legendre P. Lehmann T. N. et al . (2008). Glycinergic tonic inhibition of hippocampal neurons with depolarizing GABAergic transmission elicits histopathological signs of temporal lobe epilepsy. J. Cell. Mol. Med. 12, 28482866. 10.1111/j.1582-4934.2008.00357.x

  • 85

    Elliott R. C. Miles M. F. Lowenstein D. H. (2003). Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. J. Neurosci. 23, 22182227.

  • 86

    Fan Y. Fricker D. Brager D. H. Chen X. Lu H. C. Chitwood R. A. et al . (2005). Activity-dependent decrease of excitability in rat hippocampal neurons through increases in I(h). Nat. Neurosci. 8, 15421551. 10.1038/nn1568

  • 87

    Faulkner M. A. Burke R. A. (2013). Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel. Expert Opin. Drug Saf. 12, 847855. 10.1517/14740338.2013.823399

  • 88

    Feng Z. Chang R. C. Bing G. Hudson P. Tiao N. Jin L. et al . (1999). Long-term increase of Sp-1 transcription factors in the hippocampus after kainic acid treatment. Brain Res. Mol. Brain Res. 69, 144148. 10.1016/S0169-328X(99)00099-6

  • 89

    Francis J. Jugloff D. G. Mingo N. S. Wallace M. C. Jones O. T. Burnham W. M. et al . (1997). Kainic acid-induced generalized seizures alter the regional hippocampal expression of the rat Kv4.2 potassium channel gene. Neurosci. Lett. 232, 9194. 10.1016/S0304-3940(97)00593-4

  • 90

    Fritschy J. M. (2004). A new animal model of temporal lobe epilepsy. Epileptologie, 2128.

  • 91

    Gandolfo G. Gottesmann C. Bidard J. N. Lazdunski M. (1989a). K+ channels openers prevent epilepsy induced by the bee venom peptide MCD. Eur. J. Pharmacol. 159, 329330.

  • 92

    Gandolfo G. Romettino S. Gottesmann C. Van Luijtelaar G. Coenen A. Bidard J. N. et al . (1989b). K+ channel openers decrease seizures in genetically epileptic rats. Eur. J. Pharmacol. 167, 181183.

  • 93

    Gasparini S. Difrancesco D. (1997). Action of the hyperpolarization-activated current (Ih) blocker ZD 7288 in hippocampal CA1 neurons. Pflugers Arch. 435, 99106. 10.1007/s004240050488

  • 94

    Gavrilovici C. Pollock E. Everest M. Poulter M. O. (2012). The loss of interneuron functional diversity in the piriform cortex after induction of experimental epilepsy. Neurobiol. Dis. 48, 317328. 10.1016/j.nbd.2012.07.002

  • 95

    Ge Y. X. Liu Y. Tang H. Y. Liu X. G. Wang X. (2011). ClC-2 contributes to tonic inhibition mediated by alpha5 subunit-containing GABA(A) receptor in experimental temporal lobe epilepsy. Neuroscience186, 120127. 10.1016/j.neuroscience.2011.04.029

  • 96

    George A. L. Jr. (2004). Inherited channelopathies associated with epilepsy. Epilepsy Curr. 4, 6570. 10.1111/j.1535-7597.2004.42010.x

  • 97

    Gibbs J. W. III. Shumate M. D. Coulter D. A. (1997). Differential epilepsy-associated alterations in postsynaptic GABA(A) receptor function in dentate granule and CA1 neurons. J. Neurophysiol. 77, 19241938.

  • 98

    Glykys J. Mann E. O. Mody I. (2008). Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus?J. Neurosci. 28, 14211426. 10.1523/JNEUROSCI.4751-07.2008

  • 99

    Goddard G. V. Mcintyre D. C. Leech C. K. (1969). A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25, 295330. 10.1016/0014-4886(69)90128-9

  • 100

    Goldstein S. A. Bayliss D. A. Kim D. Lesage F. Plant L. D. Rajan S. (2005). International union of pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol. Rev. 57, 527540. 10.1124/pr.57.4.12

  • 101

    Golowasch J. Abbott L. F. Marder E. (1999). Activity-dependent regulation of potassium currents in an identified neuron of the stomatogastric ganglion of the crab Cancer borealis. J. Neurosci. 19:RC33.

  • 102

    Goodkin H. P. Joshi S. Mtchedlishvili Z. Brar J. Kapur J. (2008). Subunit-specific trafficking of GABA(A) receptors during status epilepticus. J. Neurosci. 28, 25272538. 10.1523/JNEUROSCI.3426-07.2008

  • 103

    Gower W. R. (1881). Epilepsy and Other Chronic Convulsive Disorders, their Causes, Symptoms and Treatment. London: J & A Churchill.

  • 104

    Graef J. D. Nordskog B. K. Wiggins W. F. Godwin D. W. (2009). An acquired channelopathy involving thalamic T-type Ca2+ channels after status epilepticus. J. Neurosci. 29, 44304441. 10.1523/JNEUROSCI.0198-09.2009

  • 105

    Grunze H. Von Wegerer J. Greene R. W. Walden J. (1998). Modulation of calcium and potassium currents by lamotrigine. Neuropsychobiology38, 131138. 10.1159/000026528

  • 106

    Gutman G. A. Chandy K. G. Grissmer S. Lazdunski M. McKinnon D. Pardo L. A. et al . (2005). International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 57, 473508. 10.1124/pr.57.4.10

  • 107

    Haas C. A. Dudeck O. Kirsch M. Huszka C. Kann G. Pollak S. et al . (2002). Role for reelin in the development of granule cell dispersion in temporal lobe epilepsy. J. Neurosci. 22, 57975802.

  • 108

    Hargus N. J. Nigam A. Bertram E. H. III Patel M. K. (2013). Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during epileptogenesis. J. Neurophysiol. 110, 11441157. 10.1152/jn.00383.2013

  • 109

    Harvey B. D. Sloviter R. S. (2005). Hippocampal granule cell activity and c-Fos expression during spontaneous seizures in awake, chronically epileptic, pilocarpine-treated rats: implications for hippocampal epileptogenesis. J. Comp. Neurol. 488, 442463. 10.1002/cne.20594

  • 110

    Hauser W. A. Lee J. R. (2002). Do seizures beget seizures?Prog. Brain Res. 135, 215219.

  • 111

    Häussler U. Bielefeld L. Froriep U. P. Wolfart J. Haas C. A. (2012). Septotemporal position in the hippocampal formation determines epileptic and neurogenic activity in temporal lobe epilepsy. Cereb. Cortex22, 2636. 10.1093/cercor/bhr054

  • 112

    He Y. Zorumski C. F. Mennerick S. (2002). Contribution of presynaptic Na(+) channel inactivation to paired-pulse synaptic depression in cultured hippocampal neurons. J. Neurophysiol. 87, 925936.

  • 113

    Hedrich U. B. Liautard C. Kirschenbaum D. Pofahl M. Lavigne J. Liu Y. et al . (2014). Impaired Action Potential Initiation in GABAergic Interneurons Causes Hyperexcitable Networks in an Epileptic Mouse Model Carrying a Human NaV1.1 Mutation. J. Neurosci. 34, 1487414889. 10.1523/JNEUROSCI.0721-14.2014

  • 114

    Heilstedt H. A. Burgess D. L. Anderson A. E. Chedrawi A. Tharp B. Lee O. et al . (2001). Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome. Epilepsia42, 11031111. 10.1046/j.1528-1157.2001.08801.x

  • 115

    Heinemann U. Beck H. Dreier J. P. Ficker E. Stabel J. Zhang C. L. (1992). The dentate gyrus as a regulated gate for the propagation of epileptiform activity. Epilepsy Res. Suppl. 7, 273280.

  • 116

    Heuser K. Eid T. Lauritzen F. Thoren A. E. Vindedal G. F. Tauboll E. et al . (2012). Loss of perivascular Kir4.1 potassium channels in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy. J. Neuropathol. Exp. Neurol. 71, 814825. 10.1097/NEN.0b013e318267b5af

  • 117

    Hinterkeuser S. Schroder W. Hager G. Seifert G. Blumcke I. Elger C. E. et al . (2000). Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances. Eur. J. Neurosci. 12, 20872096. 10.1046/j.1460-9568.2000.00104.x

  • 118

    Hoffman E. P. (1995). Voltage-gated ion channelopathies: inherited disorders caused by abnormal sodium, chloride, and calcium regulation in skeletal muscle. Annu. Rev. Med. 46, 431441. 10.1146/annurev.med.46.1.431

  • 119

    Houser C. R. (1990). Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy. Brain Res. 535, 195204. 10.1016/0006-8993(90)91601-C

  • 120

    Hsu D. (2007). The dentate gyrus as a filter or gate: a look back and a look ahead. Prog. Brain Res. 163, 601613. 10.1016/S0079-6123(07)63032-5

  • 121

    Hu H. J. Carrasquillo Y. Karim F. Jung W. E. Nerbonne J. M. Schwarz T. L. et al . (2006). The kv4.2 potassium channel subunit is required for pain plasticity. Neuron50, 89100. 10.1016/j.neuron.2006.03.010

  • 122

    Huang C. W. Huang C. C. Liu Y. C. Wu S. N. (2004). Inhibitory effect of lamotrigine on A-type potassium current in hippocampal neuron-derived H19-7 cells. Epilepsia45, 729736. 10.1111/j.0013-9580.2004.58403.x

  • 123

    Huang C. W. Huang C. C. Wu S. N. (2006). The opening effect of pregabalin on ATP-sensitive potassium channels in differentiated hippocampal neuron-derived H19-7 cells. Epilepsia47, 720726. 10.1111/j.1528-1167.2006.00498.x

  • 124

    Huang C. W. Huang C. C. Wu S. N. (2007). Activation by zonisamide, a newer antiepileptic drug, of large-conductance calcium-activated potassium channel in differentiated hippocampal neuron-derived H19-7 cells. J. Pharmacol. Exp. Ther. 321, 98106. 10.1124/jpet.106.116954

  • 125

    Huang Z. Walker M. C. Shah M. M. (2009). Loss of dendritic HCN1 subunits enhances cortical excitability and epileptogenesis. J. Neurosci. 29, 1097910988. 10.1523/JNEUROSCI.1531-09.2009

  • 126

    Huberfeld G. Wittner L. Clemenceau S. Baulac M. Kaila K. Miles R. et al . (2007). Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J. Neurosci. 27, 98669873. 10.1523/JNEUROSCI.2761-07.2007

  • 127

    Hyun J. H. Eom K. Lee K. H. Ho W. K. Lee S. H. (2013). Activity-dependent downregulation of D-type K+ channel subunit Kv1.2 in rat hippocampal CA3 pyramidal neurons. J. Physiol. (Lond).

  • 128

    Ishii A. Fukuma G. Uehara A. Miyajima T. Makita Y. Hamachi A. et al . (2009). A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions. Brain Dev. 31, 2733. 10.1016/j.braindev.2008.05.010

  • 129

    Isokawa M. (1996). Decrement of GABAA receptor-mediated inhibitory postsynaptic currents in dentate granule cells in epileptic hippocampus. J. Neurophysiol. 75, 19011908.

  • 130

    Isokawa M. Levesque M. F. (1991). Increased NMDA responses and dendritic degeneration in human epileptic hippocampal neurons in slices. Neurosci. Lett. 132, 212216. 10.1016/0304-3940(91)90304-C

  • 131

    Isokawa M. Mello L. E. (1991). NMDA receptor-mediated excitability in dendritically deformed dentate granule cells in pilocarpine-treated rats. Neurosci. Lett. 129, 6973. 10.1016/0304-3940(91)90722-6

  • 132

    Jabs R. Seifert G. Steinhauser C. (2008). Astrocytic function and its alteration in the epileptic brain. Epilepsia49(Suppl. 2), 312. 10.1111/j.1528-1167.2008.01488.x

  • 133

    Jefferys J. G. (1999). Hippocampal sclerosis and temporal lobe epilepsy: cause or consequence?Brain122 (Pt 6), 10071008.

  • 134

    Jensen F. E. Baram T. Z. (2000). Developmental seizures induced by common early-life insults: short- and long-term effects on seizure susceptibility. Ment. Retard. Dev. Disabil. Res. Rev. 6, 253257. 10.1002/1098-2779(2000)6:4<253::AID-MRDD4>3.0.CO;2-P

  • 135

    Jensen H. S. Grunnet M. Bastlund J. F. (2014). Therapeutic potential of Na(V)1.1 activators. Trends Pharmacol. Sci. 35, 113118. 10.1016/j.tips.2013.12.007

  • 136

    Jin W. Sugaya A. Tsuda T. Ohguchi H. Sugaya E. (2000). Relationship between large conductance calcium-activated potassium channel and bursting activity. Brain Res. 860, 2128. 10.1016/S0006-8993(00)01943-0

  • 137

    Jobst B. C. Cascino G. D. (2015). Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA313, 285293. 10.1001/jama.2014.17426

  • 138

    Jung S. Bullis J. B. Lau I. H. Jones T. D. Warner L. N. Poolos N. P. (2010). Downregulation of dendritic HCN channel gating in epilepsy is mediated by altered phosphorylation signaling. J. Neurosci. 30, 66786688. 10.1523/JNEUROSCI.1290-10.2010

  • 139

    Jung S. Jones T. D. Lugo J. N. Jr. Sheerin A. H. Miller J. W. D'ambrosio R. et al . (2007). Progressive dendritic HCN channelopathy during epileptogenesis in the rat pilocarpine model of epilepsy. J. Neurosci. 27, 1301213021. 10.1523/JNEUROSCI.3605-07.2007

  • 140

    Jung S. Warner L. N. Pitsch J. Becker A. J. Poolos N. P. (2011). Rapid loss of dendritic HCN channel expression in hippocampal pyramidal neurons following status epilepticus. J. Neurosci. 31, 1429114295. 10.1523/JNEUROSCI.1148-11.2011

  • 141

    Kanyshkova T. Meuth P. Bista P. Liu Z. Ehling P. Caputi L. et al . (2012). Differential regulation of HCN channel isoform expression in thalamic neurons of epileptic and non-epileptic rat strains. Neurobiol. Dis. 45, 450461. 10.1016/j.nbd.2011.08.032

  • 142

    Kasteleijn-Nolst Trenite D. G. Biton V. French J. A. Abou-Khalil B. Rosenfeld W. E. Diventura B. et al . (2013). Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy. Epilepsia54, 14371443. 10.1111/epi.12224

  • 143

    Kaufmann K. Romaine I. Days E. Pascual C. Malik A. Yang L. et al . (2013). ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice. ACS Chem. Neurosci. 4, 12781286. 10.1021/cn400062a

  • 144

    Ketelaars S. O. Gorter J. A. van Vliet E. A. Lopes da Silva F. H. Wadman W. J. (2001). Sodium currents in isolated rat CA1 pyramidal and dentate granule neurones in the post-status epilepticus model of epilepsy. Neuroscience105, 109120. 10.1016/S0306-4522(01)00176-2

  • 145

    Khirug S. Ahmad F. Puskarjov M. Afzalov R. Kaila K. Blaesse P. (2010). A Single Seizure episode leads to rapid functional activation of KCC2 in the neonatal rat hippocampus. J. Neurosci. 30, 1202812035. 10.1523/JNEUROSCI.3154-10.2010

  • 146

    Kienzler F. Norwood B. A. Sloviter R. S. (2009). Hippocampal injury, atrophy, synaptic reorganization, and epileptogenesis after perforant pathway stimulation-induced status epilepticus in the mouse. J. Comp. Neurol. 515, 181196. 10.1002/cne.22059

  • 147

    Kim D. S. Kim J. E. Kwak S. E. Choi H. C. Song H. K. Kimg Y. I. et al . (2007a). Up-regulated astroglial TWIK-related acid-sensitive K+ channel-1 (TASK-1) in the hippocampus of seizure-sensitive gerbils: a target of anti-epileptic drugs. Brain Res. 1185, 346358. 10.1016/j.brainres.2007.09.043

  • 148

    Kim D. S. Ryu H. J. Kim J. E. Kang T. C. (2013). The reverse roles of transient receptor potential canonical channel-3 and -6 in neuronal death following pilocarpine-induced status epilepticus. Cell. Mol. Neurobiol. 33, 99109. 10.1007/s10571-012-9875-6

  • 149

    Kim J. Jung S. C. Clemens A. M. Petralia R. S. Hoffman D. A. (2007b). Regulation of dendritic excitability by activity-dependent trafficking of the A-type K+ channel subunit Kv4.2 in hippocampal neurons. Neuron54, 933947. 10.1016/j.neuron.2007.05.026

  • 150

    Kim J. E. Kwak S. E. Choi H. C. Song H. K. Kim Y. I. Jo S. M. et al . (2008a). Voltage-gated Na+ channel II immunoreactivity is selectively up-regulated in hippocampal interneurons of seizure sensitive gerbils. Neurosci. Lett. 438, 295299. 10.1016/j.neulet.2008.04.079

  • 151

    Kim J. E. Kwak S. E. Choi S. Y. Kang T. C. (2008b). Region-specific alterations in astroglial TWIK-related acid-sensitive K+-1 channel immunoreactivity in the rat hippocampal complex following pilocarpine-induced status epilepticus. J. Comp. Neurol. 510, 463474. 10.1002/cne.21767

  • 152

    Kim J. E. Kwak S. E. Kang T. C. (2009). Upregulated TWIK-related acid-sensitive K+ channel-2 in neurons and perivascular astrocytes in the hippocampus of experimental temporal lobe epilepsy. Epilepsia50, 654663. 10.1111/j.1528-1167.2008.01957.x

  • 153

    Kim K. S. Kobayashi M. Takamatsu K. Tzingounis A. V. (2012). Hippocalcin and KCNQ channels contribute to the kinetics of the slow afterhyperpolarization. Biophys. J. 103, 24462454. 10.1016/j.bpj.2012.11.002

  • 154

    King D. Bronen R. A. Spencer D. D. Spencer S. S. (1997). Topographic distribution of seizure onset and hippocampal atrophy: relationship between MRI and depth EEG. Electroencephalogr. Clin. Neurophysiol. 103, 692697. 10.1016/S0013-4694(97)00090-4

  • 155

    Kirchheim F. Tinnes S. Haas C. A. Stegen M. Wolfart J. (2013). Regulation of action potential delays via voltage-gated potassium Kv1.1 channels in dentate granule cells during hippocampal epilepsy. Front. Cell. Neurosci. 7:248. 10.3389/fncel.2013.00248

  • 156

    Knuesel I. Zuellig R. A. Schaub M. C. Fritschy J. M. (2001). Alterations in dystrophin and utrophin expression parallel the reorganization of GABAergic synapses in a mouse model of temporal lobe epilepsy. Eur. J. Neurosci. 13, 11131124. 10.1046/j.0953-816x.2001.01476.x

  • 157

    Kobayashi M. Wen X. Buckmaster P. S. (2003). Reduced inhibition and increased output of layer II neurons in the medial entorhinal cortex in a model of temporal lobe epilepsy. J. Neurosci. 23, 84718479.

  • 158

    Kole M. H. Brauer A. U. Stuart G. J. (2007). Inherited cortical HCN1 channel loss amplifies dendritic calcium electrogenesis and burst firing in a rat absence epilepsy model. J. Physiol. 578, 507525. 10.1113/jphysiol.2006.122028

  • 159

    Kowalski J. Geuting M. Paul S. Dieni S. Laurens J. Zhao S. et al . (2010). Proper layering is important for precisely timed activation of hippocampal mossy cells. Cereb. Cortex20, 20432054. 10.1093/cercor/bhp267

  • 160

    Krook-Magnuson E. Armstrong C. Bui A. Lew S. Oijala M. Soltesz I. (2015). In vivo evaluation of the dentate gate theory in epilepsy. J. Physiol. 10.1113/JP270056

  • 161

    Kubo Y. Adelman J. P. Clapham D. E. Jan L. Y. Karschin A. Kurachi Y. et al . (2005). International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol. Rev. 57, 509526. 10.1124/pr.57.4.11

  • 162

    Kullmann D. M. Waxman S. G. (2010). Neurological channelopathies: new insights into disease mechanisms and ion channel function. J. Physiol. 588, 18231827. 10.1113/jphysiol.2010.190652

  • 163

    Kumar S. S. Buckmaster P. S. (2006). Hyperexcitability, interneurons, and loss of GABAergic synapses in entorhinal cortex in a model of temporal lobe epilepsy. J. Neurosci. 26, 46134623. 10.1523/JNEUROSCI.0064-06.2006

  • 164

    Lachance-Touchette P. Brown P. Meloche C. Kinirons P. Lapointe L. Lacasse H. et al . (2011). Novel alpha1 and gamma2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy. Eur. J. Neurosci. 34, 237249. 10.1111/j.1460-9568.2011.07767.x

  • 165

    Lau D. Vega-Saenz De Miera E. C. Contreras D. Ozaita A. Harvey M. Chow A. et al . (2000). Impaired fast-spiking, suppressed cortical inhibition, and increased susceptibility to seizures in mice lacking Kv3.2 K+ channel proteins. J. Neurosci. 20, 90719085.

  • 166

    Le Duigou C. Bouilleret V. Miles R. (2008). Epileptiform activities in slices of hippocampus from mice after intra-hippocampal injection of kainic acid. J. Physiol. 586, 48914904. 10.1113/jphysiol.2008.156281

  • 167

    Lee C. H. Liou H. H. (2014). Pregabalin activates ROMK1 channels via cAMP-dependent protein kinase and protein kinase C. Eur. J. Pharmacol. 740, 3544. 10.1016/j.ejphar.2014.06.049

  • 168

    Lee S. M. Kim J. E. Sohn J. H. Choi H. C. Lee J. S. Kim S. H. et al . (2009). Down-regulation of delayed rectifier K+ channels in the hippocampus of seizure sensitive gerbils. Brain Res. Bull. 80, 433442. 10.1016/j.brainresbull.2009.07.016

  • 169

    Levitan I. B. (1994). Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu. Rev. Physiol. 56, 193212. 10.1146/annurev.ph.56.030194.001205

  • 170

    Li K. X. Lu Y. M. Xu Z. H. Zhang J. Zhu J. M. Zhang J. M. et al . (2012). Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat. Neurosci. 15, 267273. 10.1038/nn.3006

  • 171

    Limbrick D. D. Jr. Sombati S. Delorenzo R. J. (2003). Calcium influx constitutes the ionic basis for the maintenance of glutamate-induced extended neuronal depolarization associated with hippocampal neuronal death. Cell Calcium33, 6981. 10.1016/S0143-4160(02)00054-4

  • 172

    Liu M. Pleasure S. J. Collins A. E. Noebels J. L. Naya F. J. Tsai M. J. et al . (2000). Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy. Proc. Natl. Acad. Sci. U.S.A. 97, 865870. 10.1073/pnas.97.2.865

  • 173

    Liu Y. Liu D. Printzenhoff D. Coghlan M. J. Harris R. Krafte D. S. (2002). Tenidap, a novel anti-inflammatory agent, is an opener of the inwardly rectifying K+ channel hKir2.3. Eur. J. Pharmacol. 435, 153160. 10.1016/S0014-2999(01)01590-4

  • 174

    Löscher W. Klitgaard H. Twyman R. E. Schmidt D. (2013). New avenues for anti-epileptic drug discovery and development. Nat. Rev. Drug Discov. 12, 757776. 10.1038/nrd4126

  • 175

    Lothman E. W. Stringer J. L. Bertram E. H. (1992). The dentate gyrus as a control point for seizures in the hippocampus and beyond. Epilepsy Res. Suppl. 7, 301313.

  • 176

    Loup F. Wieser H. G. Yonekawa Y. Aguzzi A. Fritschy J. M. (2000). Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J. Neurosci. 20, 54015419.

  • 177

    Lu Q. Peevey J. Jow F. Monaghan M. M. Mendoza G. Zhang H. et al . (2008). Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators). Bioorg. Med. Chem. 16, 30673075. 10.1016/j.bmc.2007.12.031

  • 178

    Ludwig A. Budde T. Stieber J. Moosmang S. Wahl C. Holthoff K. et al . (2003). Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J. 22, 216224. 10.1093/emboj/cdg032

  • 179

    Lugo J. N. Barnwell L. F. Ren Y. Lee W. L. Johnston L. D. Kim R. et al . (2008). Altered phosphorylation and localization of the A-type channel, Kv4.2 in status epilepticus. J. Neurochem. 106, 19291940. 10.1111/j.1471-4159.2008.05508.x

  • 180

    Lukasiuk K. Pitkanen A. (2004). Large-scale analysis of gene expression in epilepsy research: is synthesis already possible?Neurochem. Res. 29, 11691178. 10.1023/B:NERE.0000023604.91584.6c

  • 181

    Ma W. Berg J. Yellen G. (2007). Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J. Neurosci. 27, 36183625. 10.1523/JNEUROSCI.0132-07.2007

  • 182

    Madeja M. Margineanu D. G. Gorji A. Siep E. Boerrigter P. Klitgaard H. et al . (2003). Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?Neuropharmacology45, 661671. 10.1016/S0028-3908(03)00248-X

  • 183

    Magee J. C. (1999). Dendritic lh normalizes temporal summation in hippocampal CA1 neurons. Nat. Neurosci. 2, 508514. 10.1038/9158

  • 184

    Magloczky Z. Freund T. F. (1995). Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield. Neuroscience66, 847860. 10.1016/0306-4522(94)00613-A

  • 185

    Magloczky Z. Freund T. F. (2005). Impaired and repaired inhibitory circuits in the epileptic human hippocampus. Trends Neurosci. 28, 334340. 10.1016/j.tins.2005.04.002

  • 186

    Magloczky Z. Halasz P. Vajda J. Czirjak S. Freund T. F. (1997). Loss of Calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy. Neuroscience76, 377385. 10.1016/S0306-4522(96)00440-X

  • 187

    Main M. J. Cryan J. E. Dupere J. R. Cox B. Clare J. J. Burbidge S. A. (2000). Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol. Pharmacol. 58, 253262.

  • 188

    Marcelin B. Chauviere L. Becker A. Migliore M. Esclapez M. Bernard C. (2009). h channel-dependent deficit of theta oscillation resonance and phase shift in temporal lobe epilepsy. Neurobiol. Dis. 33, 436447. 10.1016/j.nbd.2008.11.019

  • 189

    Marder E. Goaillard J. M. (2006). Variability, compensation and homeostasis in neuron and network function. Nat. Rev. Neurosci. 7, 563574. 10.1038/nrn1949

  • 190

    Margerison J. H. Corsellis J. A. (1966). Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain89, 499530. 10.1093/brain/89.3.499

  • 191

    Martin M. S. Dutt K. Papale L. A. Dube C. M. Dutton S. B. De Haan G. et al . (2010). Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J. Biol. Chem. 285, 98239834. 10.1074/jbc.M109.078568

  • 192

    Mashimo T. Ohmori I. Ouchida M. Ohno Y. Tsurumi T. Miki T. et al . (2010). A missense mutation of the gene encoding voltage-dependent sodium channel (Nav1.1) confers susceptibility to febrile seizures in rats. J. Neurosci. 30, 57445753. 10.1523/JNEUROSCI.3360-09.2010

  • 193

    Mathern G. W. Adelson P. D. Cahan L. D. Leite J. P. (2002). Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Prog. Brain Res. 135, 237251. 10.1016/s0079-6123(02)35023-4

  • 194

    Mattia D. Nagao T. Rogawski M. A. Avoli M. (1994). Potassium channel activators counteract anoxic hyperexcitability but not 4-aminopyridine-induced epileptiform activity in the rat hippocampal slice. Neuropharmacology33, 15151522. 10.1016/0028-3908(94)90124-4

  • 195

    Mcclelland S. Flynn C. Dube C. Richichi C. Zha Q. Ghestem A. et al . (2011). Neuron-restrictive silencer factor-mediated hyperpolarization-activated cyclic nucleotide gated channelopathy in experimental temporal lobe epilepsy. Ann. Neurol. 70, 454464. 10.1002/ana.22479

  • 196

    Mcnamara J. O. (1984). Kindling: an animal model of complex partial epilepsy. Ann. Neurol. 16(Suppl.), S72S76. 10.1002/ana.410160712

  • 197

    Mehranfard N. Gholamipour-Badie H. Motamedi F. Janahmadi M. Naderi N. (2014a). The effect of paxilline on early alterations of electrophysiological properties of dentate gyrus granule cells in pilocarpine-treated rats. Iran. J. Pharm. Res. 13, 125132. 10.9734/ARRB/2014/11778

  • 198

    Mehranfard N. Gholamipour-Badie H. Motamedi F. Janahmadi M. Naderi N. (2014b). Occurrence of two types of granule cells with different excitability in rat dentate gyrus granule cell layer following pilocarpine-induced status epilepticus. Annu. Res. Rev. Biol. 4, 37073715. 10.9734/ARRB/2014/11778

  • 199

    Meier J. Semtner M. Winkelmann A. Wolfart J. (2014). Presynaptic mechanisms of neuronal plasticity and their role in epilepsy. Front. Cell. Neurosci. 8:164. 10.3389/fncel.2014.00164

  • 200

    Meier J. Semtner M. Wolfart J. (2015). Homeostasis of neuronal excitability via synaptic and intrinsic inhibitory mechanisms, in Homeostatic Control of Brain Function, eds. BoisonD.MasinoS. A. (Oxford: Oxford University Press).

  • 201

    Meldrum B. S. Rogawski M. A. (2007). Molecular targets for antiepileptic drug development. Neurotherapeutics4, 1861. 10.1016/j.nurt.2006.11.010

  • 202

    Menteyne A. Levavasseur F. Audinat E. Avignone E. (2009). Predominant functional expression of Kv1.3 by activated microglia of the hippocampus after Status epilepticus. PLoS One4:e6770. 10.1371/journal.pone.0006770

  • 203

    Misonou H. Menegola M. Mohapatra D. P. Guy L. K. Park K. S. Trimmer J. S. (2006). Bidirectional activity-dependent regulation of neuronal ion channel phosphorylation. J. Neurosci. 26, 1350513514. 10.1523/JNEUROSCI.3970-06.2006

  • 204

    Mody I. Kohr G. Otis T. S. Staley K. J. (1992a). The electrophysiology of dentate gyrus granule cells in whole-cell recordings. Epilepsy Res. Suppl. 7, 159168.

  • 205

    Mody I. Otis T. S. Staley K. J. Kohr G. (1992b). The balance between excitation and inhibition in dentate granule cells and its role in epilepsy. Epilepsy Res. Suppl. 9, 331339.

  • 206

    Molnar P. Nadler J. V. (1999). Mossy fiber-granule cell synapses in the normal and epileptic rat dentate gyrus studied with minimal laser photostimulation. J. Neurophysiol. 82, 18831894.

  • 207

    Monaghan M. M. Menegola M. Vacher H. Rhodes K. J. Trimmer J. S. (2008). Altered expression and localization of hippocampal A-type potassium channel subunits in the pilocarpine-induced model of temporal lobe epilepsy. Neuroscience156, 550562. 10.1016/j.neuroscience.2008.07.057

  • 208

    Morgan R. J. Soltesz I. (2008). Nonrandom connectivity of the epileptic dentate gyrus predicts a major role for neuronal hubs in seizures. Proc. Natl. Acad. Sci. U.S.A. 105, 61796184. 10.1073/pnas.0801372105

  • 209

    Morimoto K. Fahnestock M. Racine R. J. (2004). Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73, 160. 10.1016/j.pneurobio.2004.03.009

  • 210

    Motti D. Le Duigou C. Eugene E. Chemaly N. Wittner L. Lazarevic D. et al . (2010). Gene expression analysis of the emergence of epileptiform activity after focal injection of kainic acid into mouse hippocampus. Eur. J. Neurosci. 32, 13641379. 10.1111/j.1460-9568.2010.07403.x

  • 211

    Mucha M. Ooi L. Linley J. E. Mordaka P. Dalle C. Robertson B. et al . (2010). Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability. J. Neurosci. 30, 1323513245. 10.1523/JNEUROSCI.1981-10.2010

  • 212

    Mueller S. G. Laxer K. D. Schuff N. Weiner M. W. (2007). Voxel-based T2 relaxation rate measurements in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia48, 220228. 10.1111/j.1528-1167.2006.00916.x

  • 213

    Munoz A. Arellano J. I. Defelipe J. (2002). GABABR1 receptor protein expression in human mesial temporal cortex: changes in temporal lobe epilepsy. J. Comp. Neurol. 449, 166179. 10.1002/cne.10287

  • 214

    Nadler J. V. Perry B. W. Cotman C. W. (1978). Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature271, 676677. 10.1038/271676a0

  • 215

    Nagao Y. Harada Y. Mukai T. Shimizu S. Okuda A. Fujimoto M. et al . (2013). Expressional analysis of the astrocytic Kir4.1 channel in a pilocarpine-induced temporal lobe epilepsy model. Front. Cell. Neurosci. 7:104. 10.3389/fncel.2013.00104

  • 216

    Nassirpour R. Bahima L. Lalive A. L. Lüscher C. Lujan R. Slesinger P. A. (2010). Morphine- and CaMKII-dependent enhancement of GIRK channel signaling in hippocampal neurons. J. Neurosci. 30, 1341913430. 10.1523/JNEUROSCI.2966-10.2010

  • 217

    Noam Y. Bernard C. Baram T. Z. (2011). Towards an integrated view of HCN channel role in epilepsy. Curr. Opin. Neurobiol. 21, 873879. 10.1016/j.conb.2011.06.013

  • 218

    O'Malley D. Harvey J. (2007). MAPK-dependent actin cytoskeletal reorganization underlies BK channel activation by insulin. Eur. J. Neurosci. 25, 673682. 10.1111/j.1460-9568.2007.05347.x

  • 219

    Ogiwara I. Miyamoto H. Morita N. Atapour N. Mazaki E. Inoue I. et al . (2007). Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J. Neurosci. 27, 59035914. 10.1523/JNEUROSCI.5270-06.2007

  • 220

    Oh Y. J. Na J. Jeong J. H. Park D. K. Park K. H. Ko J. S. et al . (2012). Alterations in hyperpolarization-activated cyclic nucleotidegated cation channel (HCN) expression in the hippocampus following pilocarpine-induced status epilepticus. BMB Rep. 45, 635640. 10.5483/BMBRep.2012.45.11.091

  • 221

    Okamoto O. K. Janjoppi L. Bonone F. M. Pansani A. P. Da Silva A. V. Scorza F. A. et al . (2010). Whole transcriptome analysis of the hippocampus: toward a molecular portrait of epileptogenesis. BMC Genomics11:230. 10.1186/1471-2164-11-230

  • 222

    Okazaki M. M. Molnar P. Nadler J. V. (1999). Recurrent mossy fiber pathway in rat dentate gyrus: synaptic currents evoked in presence and absence of seizure-induced growth. J. Neurophysiol. 81, 16451660.

  • 223

    Oliveira M. S. Skinner F. Arshadmansab M. F. Garcia I. Mello C. F. Knaus H. G. et al . (2010). Altered expression and function of small-conductance (SK) Ca(2+)-activated K+ channels in pilocarpine-treated epileptic rats. Brain Res. 1348, 187199. 10.1016/j.brainres.2010.05.095

  • 224

    Olney J. W. Sharpe L. G. (1969). Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science166, 386388. 10.1126/science.166.3903.386

  • 225

    Otto J. F. Kimball M. M. Wilcox K. S. (2002). Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission. Mol. Pharmacol. 61, 921927. 10.1124/mol.61.4.921

  • 226

    Otto J. F. Yang Y. Frankel W. N. White H. S. Wilcox K. S. (2006). A spontaneous mutation involving Kcnq2 (Kv7.2) reduces M-current density and spike frequency adaptation in mouse CA1 neurons. J. Neurosci. 26, 20532059. 10.1523/JNEUROSCI.1575-05.2006

  • 227

    Pacheco Otalora L. F. Hernandez E. F. Arshadmansab M. F. Francisco S. Willis M. Ermolinsky B. et al . (2008). Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy. Brain Res. 1200, 116131. 10.1016/j.brainres.2008.01.017

  • 228

    Palma E. Amici M. Sobrero F. Spinelli G. Di Angelantonio S. Ragozzino D. et al . (2006). Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory. Proc. Natl. Acad. Sci. U.S.A. 103, 84658468. 10.1073/pnas.0602979103

  • 229

    Pathak H. R. Weissinger F. Terunuma M. Carlson G. C. Hsu F. C. Moss S. J. et al . (2007). Disrupted dentate granule cell chloride regulation enhances synaptic excitability during development of temporal lobe epilepsy. J. Neurosci. 27, 1401214022. 10.1523/JNEUROSCI.4390-07.2007

  • 230

    Pei Q. Burnet P. W. Grahame-Smith D. G. Zetterstrom T. S. (1997). Differential effects of acute and chronic electroconvulsive shock on the abundance of messenger RNAs for voltage-dependent potassium channel subunits in the rat brain. Neuroscience78, 343350. 10.1016/S0306-4522(96)00574-X

  • 231

    Peng B. W. Justice J. A. Zhang K. He X. H. Sanchez R. M. (2010). Increased basal synaptic inhibition of hippocampal area CA1 pyramidal neurons by an antiepileptic drug that enhances I(H). Neuropsychopharmacology35, 464472. 10.1038/npp.2009.150

  • 232

    Peng Z. Hauer B. Mihalek R. M. Homanics G. E. Sieghart W. Olsen R. W. et al . (2002). GABA(A) receptor changes in delta subunit-deficient mice: altered expression of alpha4 and gamma2 subunits in the forebrain. J. Comp. Neurol. 446, 179197. 10.1002/cne.10210

  • 233

    Peng Z. Huang C. S. Stell B. M. Mody I. Houser C. R. (2004). Altered expression of the delta subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy. J. Neurosci. 24, 86298639. 10.1523/JNEUROSCI.2877-04.2004

  • 234

    Penschuck S. Bastlund J. F. Jensen H. S. Stensbol T. B. Egebjerg J. Watson W. P. (2005). Changes in KCNQ2 immunoreactivity in the amygdala in two rat models of temporal lobe epilepsy. Brain Res. Mol. Brain Res. 141, 6673. 10.1016/j.molbrainres.2005.08.004

  • 235

    Peters H. C. Hu H. Pongs O. Storm J. F. Isbrandt D. (2005). Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat. Neurosci. 8, 5160. 10.1038/nn1375

  • 236

    Pongs O. (1992). Structural basis of voltage-gated K+ channel pharmacology. Trends Pharmacol. Sci. 13, 359365. 10.1016/0165-6147(92)90109-J

  • 237

    Poolos N. P. (2004). The Yin and Yang of the H-Channel and Its role in epilepsy. Epilepsy Curr. 4, 36. 10.1111/j.1535-7597.2004.04101.x

  • 238

    Poolos N. P. (2009). Genetic loss of HCN1 channels is exciting, but is it epileptic?Epilepsy Curr. 10, 5152. 10.1111/j.1535-7511.2009.01352.x

  • 239

    Poolos N. P. Johnston D. (2012). Dendritic ion channelopathy in acquired epilepsy. Epilepsia53 (Suppl. 9), 3240. 10.1111/epi.12033

  • 240

    Poolos N. P. Migliore M. Johnston D. (2002). Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites. Nat. Neurosci. 5, 767774. 10.1038/nn891

  • 241

    Pothmann L. Muller C. Averkin R. G. Bellistri E. Miklitz C. Uebachs M. et al . (2014). Function of inhibitory micronetworks is spared by Na+ channel-acting anticonvulsant drugs. J. Neurosci. 34, 97209735. 10.1523/JNEUROSCI.2395-13.2014

  • 242

    Powell K. L. Lukasiuk K. O'brien T. J. Pitkanen A. (2014). Are alterations in transmitter receptor and ion channel expression responsible for epilepsies?Adv. Exp. Med. Biol. 813, 211229. 10.1007/978-94-017-8914-1_17

  • 243

    Powell K. L. Ng C. O'brien T. J. Xu S. H. Williams D. A. Foote S. J. et al . (2008). Decreases in HCN mRNA expression in the hippocampus after kindling and status epilepticus in adult rats. Epilepsia49, 16861695. 10.1111/j.1528-1167.2008.01593.x

  • 244

    Prakriya M. Mennerick S. (2000). Selective depression of low-release probability excitatory synapses by sodium channel blockers. Neuron26, 671682. 10.1016/S0896-6273(00)81203-9

  • 245

    Ptacek L. J. (1997). Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromuscul. Disord. 7, 250255. 10.1016/S0960-8966(97)00046-1

  • 246

    Qiao X. Werkman T. R. Gorter J. A. Wadman W. J. Van Vliet E. A. (2013). Expression of sodium channel alpha subunits 1.1, 1.2 and 1.6 in rat hippocampus after kainic acid-induced epilepsy. Epilepsy Res. 106, 1728. 10.1016/j.eplepsyres.2013.06.006

  • 247

    Qiu C. Zeyda T. Johnson B. Hochgeschwender U. De Lecea L. Tallent M. K. (2008). Somatostatin receptor subtype 4 couples to the M-current to regulate seizures. J. Neurosci. 28, 35673576. 10.1523/JNEUROSCI.4679-07.2008

  • 248

    Raol Y. H. Lapides D. A. Keating J. G. Brooks-Kayal A. R. Cooper E. C. (2009). A KCNQ channel opener for experimental neonatal seizures and status epilepticus. Ann. Neurol. 65, 326336. 10.1002/ana.21593

  • 249

    Raol Y. H. Lund I. V. Bandyopadhyay S. Zhang G. Roberts D. S. Wolfe J. H. et al . (2006a). Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J. Neurosci. 26, 1134211346. 10.1523/JNEUROSCI.3329-06.2006

  • 250

    Raol Y. H. Zhang G. Lund I. V. Porter B. E. Maronski M. A. Brooks-Kayal A. R. (2006b). Increased GABA(A)-receptor alpha1-subunit expression in hippocampal dentate gyrus after early-life status epilepticus. Epilepsia47, 16651673. 10.1111/j.1528-1167.2006.00640.x

  • 251

    Raza M. Blair R. E. Sombati S. Carter D. S. Deshpande L. S. Delorenzo R. J. (2004). Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy. Proc. Natl. Acad. Sci. U.S.A. 101, 1752217527. 10.1073/pnas.0408155101

  • 252

    Riazanski V. Deriy L. V. Shevchenko P. D. Le B. Gomez E. A. Nelson D. J. (2011). Presynaptic CLC-3 determines quantal size of inhibitory transmission in the hippocampus. Nat. Neurosci. 14, 487494. 10.1038/nn.2775

  • 253

    Rinke I. Artmann J. Stein V. (2010). ClC-2 voltage-gated channels constitute part of the background conductance and assist chloride extrusion. J. Neurosci. 30, 47764786. 10.1523/JNEUROSCI.6299-09.2010

  • 254

    Robbins C. A. Tempel B. L. (2012). Kv1.1 and Kv1.2: similar channels, different seizure models. Epilepsia53(Suppl. 1), 134141. 10.1111/j.1528-1167.2012.03484.x

  • 255

    Roeloffs R. Wickenden A. D. Crean C. Werness S. Mcnaughton-Smith G. Stables J. et al . (2008). In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models. J. Pharmacol. Exp. Ther. 326, 818828. 10.1124/jpet.108.137794

  • 256

    Rogawski M. A. Löscher W. (2004). The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 5, 553564. 10.1038/nrn1430

  • 257

    Rossignol E. Kruglikov I. Van Den Maagdenberg A. M. Rudy B. Fishell G. (2013). CaV 2.1 ablation in cortical interneurons selectively impairs fast-spiking basket cells and causes generalized seizures. Ann. Neurol. 74, 209222. 10.1002/ana.23913

  • 258

    Rostock A. Tober C. Rundfeldt C. Bartsch R. Engel J. Polymeropoulos E. E. et al . (1996). D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res. 23, 211223. 10.1016/0920-1211(95)00101-8

  • 259

    Rundfeldt C. Netzer R. (2000). The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits. Neurosci. Lett. 282, 7376. 10.1016/S0304-3940(00)00866-1

  • 260

    Ruppersberg J. P. Stocker M. Pongs O. Heinemann S. H. Frank R. Koenen M. (1991). Regulation of fast inactivation of cloned mammalian IK(A) channels by cysteine oxidation. Nature352, 711714. 10.1038/352711a0

  • 261

    Rüschenschmidt C. Chen J. Becker A. Riazanski V. Beck H. (2006). Functional properties and oxidative modulation of A-type K currents in hippocampal granule cells of control and chronically epileptic rats. Eur. J. Neurosci. 23, 675685. 10.1111/j.1460-9568.2006.04608.x

  • 262

    Sanabria E. R. Su H. Yaari Y. (2001). Initiation of network bursts by Ca2+-dependent intrinsic bursting in the rat pilocarpine model of temporal lobe epilepsy. J. Physiol. 532, 205216. 10.1111/j.1469-7793.2001.0205g.x

  • 263

    Santoro B. Lee J. Y. Englot D. J. Gildersleeve S. Piskorowski R. A. Siegelbaum S. A. et al . (2010). Increased seizure severity and seizure-related death in mice lacking HCN1 channels. Epilepsia51, 16241627. 10.1111/j.1528-1167.2010.02554.x

  • 264

    Scharfman H. E. (2002). Epilepsy as an example of neural plasticity. Neuroscientist8, 154173. 10.1177/107385840200800211

  • 265

    Scharfman H. E. Goodman J. H. Sollas A. L. (2000). Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J. Neurosci. 20, 61446158.

  • 266

    Scharfman H. E. Sollas A. L. Berger R. E. Goodman J. H. (2003). Electrophysiological evidence of monosynaptic excitatory transmission between granule cells after seizure-induced mossy fiber sprouting. J. Neurophysiol. 90, 25362547. 10.1152/jn.00251.2003

  • 267

    Schenzer A. Friedrich T. Pusch M. Saftig P. Jentsch T. J. Grotzinger J. et al . (2005). Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J. Neurosci. 25, 50515060. 10.1523/JNEUROSCI.0128-05.2005

  • 268

    Schroeder B. C. Kubisch C. Stein V. Jentsch T. J. (1998). Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature396, 687690. 10.1038/25367

  • 269

    Schulte U. Thumfart J. O. Klocker N. Sailer C. A. Bildl W. Biniossek M. et al . (2006). The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron49, 697706. 10.1016/j.neuron.2006.01.033

  • 270

    Schulz R. Kirschstein T. Brehme H. Porath K. Mikkat U. Köhling R. (2012). Network excitability in a model of chronic temporal lobe epilepsy critically depends on SK channel-mediated AHP currents. Neurobiol. Dis. 45, 337347. 10.1016/j.nbd.2011.08.019

  • 271

    Schwob J. E. Fuller T. Price J. L. Olney J. W. (1980). Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience5, 9911014. 10.1016/0306-4522(80)90181-5

  • 272

    Selke K. Muller A. Kukley M. Schramm J. Dietrich D. (2006). Firing pattern and calbindin-D28k content of human epileptic granule cells. Brain Res. 1120, 191201. 10.1016/j.brainres.2006.08.072

  • 273

    Shah M. M. Anderson A. E. Leung V. Lin X. Johnston D. (2004). Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons. Neuron44, 495508. 10.1016/j.neuron.2004.10.011

  • 274

    Shah M. M. Huang Z. Martinello K. (2013). HCN and KV7 (M-) channels as targets for epilepsy treatment. Neuropharmacology69, 7581. 10.1016/j.neuropharm.2012.03.005

  • 275

    Shin M. Brager D. Jaramillo T. C. Johnston D. Chetkovich D. M. (2008). Mislocalization of h channel subunits underlies h channelopathy in temporal lobe epilepsy. Neurobiol. Dis. 32, 2636. 10.1016/j.nbd.2008.06.013

  • 276

    Shruti S. Clem R. L. Barth A. L. (2008). A seizure-induced gain-of-function in BK channels is associated with elevated firing activity in neocortical pyramidal neurons. Neurobiol. Dis. 30, 323330. 10.1016/j.nbd.2008.02.002

  • 277

    Sicca F. Imbrici P. D'adamo M. C. Moro F. Bonatti F. Brovedani P. et al . (2011). Autism with seizures and intellectual disability: possible causative role of gain-of-function of the inwardly-rectifying K+ channel Kir4.1. Neurobiol. Dis. 43, 239247. 10.1016/j.nbd.2011.03.016

  • 278

    Signorini S. Liao Y. J. Duncan S. A. Jan L. Y. Stoffel M. (1997). Normal cerebellar development but susceptibility to seizures in mice labievcking G protein-coupled, inwardly rectifying K+ channel GIRK2. Proc. Natl. Acad. Sci. U.S.A. 94, 923927. 10.1073/pnas.94.3.923

  • 279

    Sills G. J. (2007). Seizures beget seizures: a lack of experimental evidence and clinical relevance fails to dampen enthusiasm. Epilepsy Curr. 7, 103104. 10.1111/j.1535-7511.2007.00189.x

  • 280

    Singh N. A. Charlier C. Stauffer D. Dupont B. R. Leach R. J. Melis R. et al . (1998). A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 18, 2529. 10.1038/ng0198-25

  • 281

    Singh N. A. Otto J. F. Dahle E. J. Pappas C. Leslie J. D. Vilaythong A. et al . (2008). Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization. J. Physiol. (Lond). 586, 34053423. 10.1113/jphysiol.2008.154971

  • 282

    Sloviter R. S. (1987). Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science235, 7376. 10.1126/science.2879352

  • 283

    Sloviter R. S. (1994). The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann. Neurol. 35, 640654. 10.1002/ana.410350604

  • 284

    Smart S. L. Lopantsev V. Zhang C. L. Robbins C. A. Wang H. Chiu S. Y. et al . (1998). Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron20, 809819. 10.1016/S0896-6273(00)81018-1

  • 285

    Smith S. E. Xu L. Kasten M. R. Anderson M. P. (2012). Mutant LGI1 inhibits seizure-induced trafficking of Kv4.2 potassium channels. J. Neurochem. 120, 611621. 10.1111/j.1471-4159.2011.07605.x

  • 286

    Sosanya N. M. Brager D. H. Wolfe S. Niere F. Raab-Graham K. F. (2014). Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis. Neurobiol. Dis. 73C, 96105. 10.1016/j.nbd.2014.09.011

  • 287

    Spencer S. S. (2002). Neural networks in human epilepsy: evidence of and implications for treatment. Epilepsia43, 219227. 10.1046/j.1528-1157.2002.26901.x

  • 288

    Spencer S. S. Spencer D. D. (1994). Entorhinal-hippocampal interactions in medial temporal lobe epilepsy. Epilepsia35, 721727. 10.1111/j.1528-1157.1994.tb02502.x

  • 289

    Spigelman I. Li Z. Banerjee P. K. Mihalek R. M. Homanics G. E. Olsen R. W. (2002). Behavior and physiology of mice lacking the GABAA-receptor delta subunit. Epilepsia43(Suppl. 5), 38. 10.1046/j.1528-1157.43.s.5.8.x

  • 290

    Splinter M. Y. (2013). Efficacy of retigabine in adjunctive treatment of partial onset seizures in adults. J. Cent. Nerv. Syst. Dis. 5, 3141. 10.4137/JCNSD.S9299

  • 291

    Stabel J. Ficker E. Heinemann U. (1992). Young CA1 pyramidal cells of rats, but not dentate gyrus granule cells, express a delayed inward rectifying current with properties of IQ. Neurosci. Lett. 135, 231234. 10.1016/0304-3940(92)90443-B

  • 292

    Staley K. J. Mody I. (1992). Shunting of excitatory input to dentate gyrus granule cells by a depolarizing GABAA receptor-mediated postsynaptic conductance. J. Neurophysiol. 68, 197212.

  • 293

    Stegen M. Kirchheim F. Hanuschkin A. Staszewski O. Veh R. W. Wolfart J. (2012). Adaptive intrinsic plasticity in human dentate gyrus granule cells during temporal lobe epilepsy. Cereb. Cortex22, 20872101. 10.1093/cercor/bhr294

  • 294

    Stegen M. Young C. C. Haas C. A. Zentner J. Wolfart J. (2009). Increased leak conductance in dentate gyrus granule cells of temporal lobe epilepsy patients with Ammon's horn sclerosis. Epilepsia50, 646653. 10.1111/j.1528-1167.2009.02025.x

  • 295

    Stogmann E. Lichtner P. Baumgartner C. Schmied M. Hotzy C. Asmus F. et al . (2006). Mutations in the CLCN2 gene are a rare cause of idiopathic generalized epilepsy syndromes. Neurogenetics7, 265268. 10.1007/s10048-006-0057-x

  • 296

    Strauss U. Kole M. H. Brauer A. U. Pahnke J. Bajorat R. Rolfs A. et al . (2004). An impaired neocortical Ih is associated with enhanced excitability and absence epilepsy. Eur. J. Neurosci. 19, 30483058. 10.1111/j.0953-816X.2004.03392.x

  • 297

    Streit A. K. Derst C. Wegner S. Heinemann U. Zahn R. K. Decher N. (2011). RNA editing of Kv1.1 channels may account for reduced ictogenic potential of 4-aminopyridine in chronic epileptic rats. Epilepsia52, 645648. 10.1111/j.1528-1167.2011.02986.x

  • 298

    Su H. Sochivko D. Becker A. Chen J. Jiang Y. Yaari Y. et al . (2002). Upregulation of a T-type Ca2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus. J. Neurosci. 22, 36453655.

  • 299

    Su T. Cong W. D. Long Y. S. Luo A. H. Sun W. W. Deng W. Y. et al . (2008). Altered expression of voltage-gated potassium channel 4.2 and voltage-gated potassium channel 4-interacting protein, and changes in intracellular calcium levels following lithium-pilocarpine-induced status epilepticus. Neuroscience157, 566576. 10.1016/j.neuroscience.2008.09.027

  • 300

    Sun C. Mtchedlishvili Z. Erisir A. Kapur J. (2007). Diminished neurosteroid sensitivity of synaptic inhibition and altered location of the alpha4 subunit of GABA(A) receptors in an animal model of epilepsy. J. Neurosci. 27, 1264112650. 10.1523/JNEUROSCI.4141-07.2007

  • 301

    Sun Y. Wu Z. Kong S. Jiang D. Pitre A. Wang Y. et al . (2013). Regulation of epileptiform activity by two distinct subtypes of extrasynaptic GABAA receptors. Mol. Brain6:21. 10.1186/1756-6606-6-21

  • 302

    Surges R. Freiman T. M. Feuerstein T. J. (2003). Gabapentin increases the hyperpolarization-activated cation current Ih in rat CA1 pyramidal cells. Epilepsia44, 150156. 10.1046/j.1528-1157.2003.36802.x

  • 303

    Sutula T. Cascino G. Cavazos J. Parada I. Ramirez L. (1989). Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 26, 321330. 10.1002/ana.410260303

  • 304

    Sutula T. P. Hagen J. Pitkanen A. (2003). Do epileptic seizures damage the brain?Curr. Opin. Neurol. 16, 189195. 10.1097/01.wco.0000063770.15877.bc

  • 305

    Suzuki F. Heinrich C. Boehrer A. Mitsuya K. Kurokawa K. Matsuda M. et al . (2005). Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy. Epilepsia46, 193202. 10.1111/j.0013-9580.2005.35504.x

  • 306

    Suzuki F. Junier M. P. Guilhem D. Sorensen J. C. Onteniente B. (1995). Morphogenetic effect of kainate on adult hippocampal neurons associated with a prolonged expression of brain-derived neurotrophic factor. Neuroscience64, 665674. 10.1016/0306-4522(94)00463-F

  • 307

    Sypert G. W. Ward A. A. Jr. (1967). The hyperexcitable neuron: microelectrode studies of the chronic epileptic focus in the intact, awake monkey. Exp. Neurol. 19, 104114. 10.1016/0014-4886(67)90010-6

  • 308

    Tatulian L. Delmas P. Abogadie F. C. Brown D. A. (2001). Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci. 21, 55355545.

  • 309

    Tauck D. L. Nadler J. V. (1985). Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J. Neurosci. 5, 10161022.

  • 310

    Taverna S. Tkatch T. Metz A. E. Martina M. (2005). Differential expression of TASK channels between horizontal interneurons and pyramidal cells of rat hippocampus. J. Neurosci. 25, 91629170. 10.1523/JNEUROSCI.2454-05.2005

  • 311

    Tellez-Zenteno J. F. Hernandez-Ronquillo L. (2012). A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res. Treat. 2012:630853. 10.1155/2012/630853

  • 312

    Thom M. Mathern G. W. Cross J. H. Bertram E. H. (2010). Mesial temporal lobe epilepsy: How do we improve surgical outcome?Ann. Neurol. 68, 424434. 10.1002/ana.22142

  • 313

    Thom M. Sisodiya S. M. Beckett A. Martinian L. Lin W. R. Harkness W. et al . (2002). Cytoarchitectural abnormalities in hippocampal sclerosis. J. Neuropathol. Exp. Neurol. 61, 510519.

  • 314

    Tomlinson S. E. Tan S. V. Kullmann D. M. Griggs R. C. Burke D. Hanna M. G. et al . (2010). Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1. Brain133, 35303540. 10.1093/brain/awq318

  • 315

    Tsaur M. L. Sheng M. Lowenstein D. H. Jan Y. N. Jan L. Y. (1992). Differential expression of K+ channel mRNAs in the rat brain and down-regulation in the hippocampus following seizures. Neuron8, 10551067. 10.1016/0896-6273(92)90127-Y

  • 316

    Turrigiano G. Lemasson G. Marder E. (1995). Selective regulation of current densities underlies spontaneous changes in the activity of cultured neurons. J. Neurosci. 15, 36403652.

  • 317

    Turrigiano G. G. Nelson S. B. (2004). Homeostatic plasticity in the developing nervous system. Nat. Rev. Neurosci. 5, 97107. 10.1038/nrn1327

  • 318

    Turski L. Ikonomidou C. Turski W. A. Bortolotto Z. A. Cavalheiro E. A. (1989). Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse3, 154171. 10.1002/syn.890030207

  • 319

    Turski W. A. Cavalheiro E. A. Schwarz M. Czuczwar S. J. Kleinrok Z. Turski L. (1983). Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 9, 315335. 10.1016/0166-4328(83)90136-5

  • 320

    Van Welie I. Van Hooft J. A. Wadman W. J. (2004). Homeostatic scaling of neuronal excitability by synaptic modulation of somatic hyperpolarization-activated Ih channels. Proc. Natl. Acad. Sci. U.S.A. 101, 51235128. 10.1073/pnas.0307711101

  • 321

    Van Welie I. Van Hooft J. A. Wadman W. J. (2006). Background activity regulates excitability of rat hippocampal CA1 pyramidal neurons by adaptation of a K+ conductance. J. Neurophysiol. 95, 20072012. 10.1152/jn.00220.2005

  • 322

    Varga A. W. Yuan L. L. Anderson A. E. Schrader L. A. Wu G. Y. Gatchel J. R. et al . (2004). Calcium-calmodulin-dependent kinase II modulates Kv4.2 channel expression and upregulates neuronal A-type potassium currents. J. Neurosci. 24, 36433654. 10.1523/JNEUROSCI.0154-04.2004

  • 323

    Vida I. (2009). 'Leaky' neurons in the epileptic hippocampus: should we get excited?J. Physiol. 587, 41274128. 10.1113/jphysiol.2009

  • 324

    Vida I. Bartos M. Jonas P. (2006). Shunting inhibition improves robustness of gamma oscillations in hippocampal interneuron networks by homogenizing firing rates. Neuron49, 107117. 10.1016/j.neuron.2005.11.036

  • 325

    Walleigh D. J. Legido A. Valencia I. (2013). Ring chromosome 20: a pediatric potassium channelopathy responsive to treatment with ezogabine. Pediatr. Neurol. 49, 368369. 10.1016/j.pediatrneurol.2013.06.005

  • 326

    Waxman S. G. (2001). Transcriptional channelopathies: an emerging class of disorders. Nat. Rev. Neurosci. 2, 652659. 10.1038/35090026

  • 327

    Weckhuysen S. Ivanovic V. Hendrickx R. Van Coster R. Hjalgrim H. Moller R. S. et al . (2013). Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients. Neurology81, 16971703. 10.1212/01.wnl.0000435296.72400.a1

  • 328

    Wei A. D. Gutman G. A. Aldrich R. Chandy K. G. Grissmer S. Wulff H. (2005). International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol. Rev. 57, 463472. 10.1124/pr.57.4.9

  • 329

    Wellmer J. Su H. Beck H. Yaari Y. (2002). Long-lasting modification of intrinsic discharge properties in subicular neurons following status epilepticus. Eur. J. Neurosci. 16, 259266. 10.1046/j.1460-9568.2002.02086.x

  • 330

    Wenzel H. J. Vacher H. Clark E. Trimmer J. S. Lee A. L. Sapolsky R. M. et al . (2007). Structural consequences of Kcna1 gene deletion and transfer in the mouse hippocampus. Epilepsia48, 20232046. 10.1111/j.1528-1167.2007.01189.x

  • 331

    Westenbroek R. E. Bausch S. B. Lin R. C. Franck J. E. Noebels J. L. Catterall W. A. (1998). Upregulation of L-type Ca2+ channels in reactive astrocytes after brain injury, hypomyelination, and ischemia. J. Neurosci. 18, 23212334.

  • 332

    Whitaker W. R. Faull R. L. Dragunow M. Mee E. W. Emson P. C. Clare J. J. (2001). Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. Neuroscience106, 275285. 10.1016/S0306-4522(01)00212-3

  • 333

    Wickenden A. D. (2002). Potassium channels as anti-epileptic drug targets. Neuropharmacology43, 10551060. 10.1016/S0028-3908(02)00237-X

  • 334

    Wickenden A. D. Krajewski J. L. London B. Wagoner P. K. Wilson W. A. Clark S. et al . (2008). N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator. Mol. Pharmacol. 73, 977986. 10.1124/mol.107.043216

  • 335

    Wickenden A. D. Yu W. Zou A. Jegla T. Wagoner P. K. (2000). Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol. Pharmacol. 58, 591600.

  • 336

    Wierschke S. Lehmann T. N. Dehnicke C. Horn P. Nitsch R. Deisz R. A. (2010). Hyperpolarization-activated cation currents in human epileptogenic neocortex. Epilepsia51, 404414. 10.1111/j.1528-1167.2009.02275.x

  • 337

    Wimmer V. C. Reid C. A. So E. Y. Berkovic S. F. Petrou S. (2010). Axon initial segment dysfunction in epilepsy. J. Physiol. 588, 18291840. 10.1113/jphysiol.2010.188417

  • 338

    Wolfart J. Debay D. Le Masson G. Destexhe A. Bal T. (2005). Synaptic background activity controls spike transfer from thalamus to cortex. Nat. Neurosci. 8, 17601767. 10.1038/nn1591

  • 339

    Wolfart J. Roeper J. (2002). Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. J. Neurosci. 22, 34043413.

  • 340

    Wykes R. C. Heeroma J. H. Mantoan L. Zheng K. Macdonald D. C. Deisseroth K. et al . (2012). Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci. Transl. Med. 4, 161152. 10.1126/scitranslmed.3004190

  • 341

    Wyler A. R. Dohan F. C. Schweitzer J. B. Berry A. D. (1992). A grading system for hippocampal sclerosis. J. Epilepsy5, 220225. 10.1016/S0896-6974(05)80120-3

  • 342

    Xu J. H. Long L. Tang Y. C. Hu H. T. Tang F. R. (2007). Ca(v)1.2, Ca(v)1.3, and Ca(v)2.1 in the mouse hippocampus during and after pilocarpine-induced status epilepticus. Hippocampus17, 235251. 10.1002/hipo.20263

  • 343

    Xu L. Hao Y. Wu X. Yu P. Zhu G. Hong Z. (2013a). Tenidap, an agonist of the inwardly rectifying K+ channel Kir2.3, delays the onset of cortical epileptiform activity in a model of chronic temporal lobe epilepsy. Neurol. Res. 35, 561567. 10.1179/1743132813Y.0000000157

  • 344

    Xu X. Guo F. Lv X. Feng R. Min D. Ma L. et al . (2013b). Abnormal changes in voltage-gated sodium channels Na(V)1.1, Na(V)1.2, Na(V)1.3, Na(V)1.6 and in calmodulin/calmodulin-dependent protein kinase II, within the brains of spontaneously epileptic rats and tremor rats. Brain Res. Bull. 96, 19. 10.1016/j.brainresbull.2013.04.003

  • 345

    Yaari Y. Beck H. (2002). “Epileptic neurons” in temporal lobe epilepsy. Brain Pathol. 12, 234239. 10.1111/j.1750-3639.2002.tb00438.x

  • 346

    Yamada K. Ji J. J. Yuan H. Miki T. Sato S. Horimoto N. et al . (2001). Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science292, 15431546. 10.1126/science.1059829

  • 347

    Yim M. Y. Hanuschkin A. Wolfart J. (2015). Intrinsic rescaling of granule cells restores pattern separation ability of a dentate gyrus network model during epileptic hyperexcitability. Hippocampus25, 297308. 10.1002/hipo.22373

  • 348

    Young C. C. Stegen M. Bernard R. Muller M. Bischofberger J. Veh R. W. et al . (2009). Upregulation of inward rectifier K+ (Kir2) channels in dentate gyrus granule cells in temporal lobe epilepsy. J. Physiol. 587, 42134233. 10.1113/jphysiol.2009.170746

  • 349

    Yu J. Proddutur A. Elgammal F. S. Ito T. Santhakumar V. (2013). Status epilepticus enhances tonic GABA currents and depolarizes GABA reversal potential in dentate fast-spiking basket cells. J. Neurophysiol. 109, 17461763. 10.1152/jn.00891.2012

  • 350

    Yus-Najera E. Munoz A. Salvador N. Jensen B. S. Rasmussen H. B. Defelipe J. et al . (2003). Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation. Neuroscience120, 353364. 10.1016/S0306-4522(03)00321-X

  • 351

    Zha Q. Brewster A. L. Richichi C. Bender R. A. Baram T. Z. (2008). Activity-dependent heteromerization of the hyperpolarization-activated, cyclic-nucleotide gated (HCN) channels: role of N-linked glycosylation. J. Neurochem. 105, 6877. 10.1111/j.1471-4159.2007.05110.x

  • 352

    Zhang G. Raol Y. H. Hsu F. C. Coulter D. A. Brooks-Kayal A. R. (2004). Effects of status epilepticus on hippocampal GABAA receptors are age-dependent. Neuroscience125, 299303. 10.1016/j.neuroscience.2004.01.040

  • 353

    Zhang K. Peng B. W. Sanchez R. M. (2006). Decreased IH in hippocampal area CA1 pyramidal neurons after perinatal seizure-inducing hypoxia. Epilepsia47, 10231028. 10.1111/j.1528-1167.2006.00574.x

  • 354

    Zhang N. Wei W. Mody I. Houser C. R. (2007). Altered localization of GABA(A) receptor subunits on dentate granule cell dendrites influences tonic and phasic inhibition in a mouse model of epilepsy. J. Neurosci. 27, 75207531. 10.1523/JNEUROSCI.1555-07.2007

  • 355

    Zhou P. Yu H. Gu M. Nan F. J. Gao Z. Li M. (2013). Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels. Proc. Natl. Acad. Sci. U.S.A. 110, 87268731. 10.1073/pnas.1302167110

  • 356

    Ziemann A. E. Schnizler M. K. Albert G. W. Severson M. A. Howard M. A. 3rd Welsh M. J. et al . (2008). Seizure termination by acidosis depends on ASIC1a. Nat. Neurosci. 11, 816822. 10.1038/nn.2132

  • 357

    Zuberi S. M. Eunson L. H. Spauschus A. De Silva R. Tolmie J. Wood N. W. et al . (1999). A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain122(Pt 5), 817825.

Summary

Keywords

hippocampus, homeostasis, kainic acid, pilocarpine, channelacoids

Citation

Wolfart J and Laker D (2015) Homeostasis or channelopathy? Acquired cell type-specific ion channel changes in temporal lobe epilepsy and their antiepileptic potential. Front. Physiol. 6:168. doi: 10.3389/fphys.2015.00168

Received

04 March 2015

Accepted

19 May 2015

Published

15 June 2015

Volume

6 - 2015

Edited by

Maria Cristina D'Adamo, Charité - Universitätsmedizin Berlin, Germany

Reviewed by

Imre Vida, Charité - Universitätsmedizin Berlin, Germany; Giuseppe Di Giovanni, University of Malta, Malta

Copyright

*Correspondence: Jakob Wolfart, Oscar Langendorff Institute of Physiology, University of Rostock, Gertrudenstr. 9, 18057 Rostock, Germany

This article was submitted to Membrane Physiology and Membrane Biophysics, a section of the journal Frontiers in Physiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics